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The preparation of a series of diastereoisomeric tetracamphorsulfonates derived from 
racemic tetramethoxyresorcin[4]arenes was achieved by reactions using an excess of 
(S)-(+)-10-camphorsulfonyl chloride in pyridine followed by isolation using flash 
chromatography. The same tetracamphorsulfonates were obtained in reactions of (S)-
(+)-10-camphorsulfonyl chloride with the anions obtained by tetradeprotonation of a 
number of tetramethoxyresorcin[4]arenes using n-butyllithium in tetrahydrofuran. 
Mono-, di-, and tricamphorsulfonates were also prepared following selective 
deprotonation. In the case of reactions using tetraisopropyloxy- and 
tetracyclopentyloxyresorcin[4]arenes, only the mono- and dicamphorsulfonates were 
formed. X-ray crystallographic analysis established the absolute configurations in the 
case of three diastereoisomerically pure tetracamphorsulfonates, including a 
diastereoisomer prepared from 2,8,14,20-tetra-2-methylpropyl-6,12,18,24-
tetramethoxyresorcin[4]arene. An additional pair of diastereoisomers was also prepared 
from (R)-(–)-10-camphorsulfonyl chloride and 2,8,14,20-tetra-2-methylpropyl-
6,12,18,24-tetramethoxyresorcin[4]arene. Hydrolytic removal of the camphorsulfonyl 
residue(s) from the various diastereoisomers gave enantiomers of known absolute 
configurations. In some cases the chiral non-racemic tetraalkoxyresorcin[4]arenes were 
converted into known tetrabenzoxazine derivatives using N,N-bis(methoxymethyl)-(S)-




The chemistry of calixarenes is widely studied and has provided a diverse range of molecular 
assemblies that have been used for a variety of purposes; the topic continues to generate 
considerable interest.1 The acid catalysed interaction of aldehydes with resorcinol provides a high 
yielding route to a range of cyclic tetramers that has made the study of resorcin[4]arenes, for 
example 1, particularly attractive.2 The dissymmetry generated by unsymmetrical substitution of 
calixarenes is recognized as being related to the non-planar structures of the parent compounds,3a 
although a number of chiral calixarene conformers are racemized thermally by processes involving 
'through-the-annulus rotation'.3b The first example of the optical resolution of a chiral calixarene used 
chiral liquid chromatography.3c Although considerable effort has been devoted to the synthesis of 
inherently chiral calixarenes, in the vast majority of published examples the products have been 
obtained as racemates, which have defied resolution except by using chiral HPLC techniques.4 This 
has inevitably meant that only very small amounts of optically pure material has been available for 
use in other studies. A solution to this problem was provided by studies carried out by us5a,b and 
others5c using chiral non-racemic α-methylbenzylamines, and resulted in the highly diastereoselective 
formation of tetrabenzoxazines derived from a number of resorcin[4]arenes, for example the 
compounds 2. The methylation of the residual phenolic hydroxy groups present in the single 
diastereoisomers was achieved in high yields on multigram scales in order to preclude 
diastereoisomerization as well as the loss of axial chirality after ring opening of the 1,3-oxazine ring 
and removal of the chiral auxiliary.6a The representation of the compounds 2, in Figure 1, is drawn 
using the convention that the polar groups are viewed from above and the depending groups (R) are 
in pseudo-axial orientations: the stereogenic centres at the inter-ring positions are therefore of S-
chirality with the axis of chirality being P (= axial-R).6b Additional examples, including where in 































































Figure 1. Representation of Resorcin[4]arenes, including Axial Stereochemistry  
 
The boron trifluoride catalysed reaction of, for example, octanal with 3-methoxyphenol, that resulted 
in the formation of a racemic tetramethoxyresorcin[4]arene, provided a route to a range of 
tetramethoxyresorcin[4]arene derivatives.7 We extended the method to the preparation of additional 
tetraalkoxyresorcin[4]arene derivatives:8 the racemic tetraalkoxyresorcin[4]arenes 4a–4f were 
prepared, in each case in good to excellent yields, as shown in Scheme 1, by the interaction of boron 
trifluoride (200 mol%) with, for example 1,1-dimethoxyalkanes or aldehydes, and for example the 3-














Scheme 1.  Formation of Racemic Tetraalkoxyresorcinarenes
4a, R1 = n-C3H7, R
2 = Me
4b, R1 = n-C5H11,R
2 = Me
4c, R1 = n-C7H15, R
2 = Me
4d, R1 = n-C11H23, R
2 = Me
4e, R1 = n-C5H11, R
2 = i-Pr
4f,  R1 = n-C5H11, R
2 = cyclopentyl
Racemic
3a, R2 = Me
3b, R2 = i-Pr







The preparation of the racemic tetramethoxyresorcin[4]arene related to 4a-f, derived by the 
interaction of 3-methylbutanal with 3-methoxyphenol, conversion into a pair of 
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monocamphorsulfonates, and their separation and isolation on a small scale by chiral HPLC in 13% 
and 16% yields has been reported previously.4k,l However, the absolute configurations of the 
enantiomers that were obtained after hydrolysis were not established.  
 
Results and Discussion 
 
In our related work we initially studied reactions of the resorcinarenes 4a to f. The conversion into 
diastereoisomeric camphorsulfonates could be achieved, in principle, either by a reaction of the 
racemic tetramethoxyresorcin[4]arenes with (S)-(+)-10-camphorsulfonyl chloride in pyridine or by 
using our low temperature deprotonation protocol,6 in which hydroxyresorcin[4]arenes are reacted 
with n-butyllithium at –78 °C in THF followed by reaction with the electrophile, in this case (S)-(+)-
10-camphorsulfonyl chloride. It is clear that the establishment of the absolute configurations of the 
(S)-(+)-10-camphorsulfonates followed by hydrolysis would allow the determination of the absolute 
configurations of the enantiomers of the tetraalkoxyresorcin[4]arenes. The absolute configurations 
of the enantiomeric tetraalkoxyresorcin[4]arenes could also be established by reference to the 
known absolute configurations of chiral non-racemic tetrabenzoxazines such as the compounds 5 
and 6, shown in Figure 2, whose structures were known from X-ray crystallographic data.6b When 
the study, conducted at Loughborough and Curtin, including the determination of the absolute 
configurations of a number of camphorsulfonates, derived from racemic 
tetraalkoxyresorcin[4]arenes, and their hydrolysis products, was almost ready for publication, the 
absolute configurations of the tetramethoxyresorcinarenes 7, derived from 3-methylbutanal and 3-
methoxyphenol were published.9 The Loughborough and Curtin groups were surprised that the 
results of their study were not in accord with the published results and the Loughborough group 
therefore repeated their experiments. The Loughborough group also prepared and used the racemic 
mixture of resorcin[4]arenes 7 in order to prepare tetracamphorsulfonates also using (S)-(+)-10-
camphorsulfonyl chloride. A very recent publication10 also used the absolute configurations that 
were reported earlier.9 Our repeated reactions, including a complete repetition of the experiments 
using an enantiomerically pure sample of the compound 7, that involved the formation of a 
crystalline amide, was carried out by the Bielefeld group,11 confirmed the initial results of the 
Loughborough and Curtin group. We now report a full account of all of our studies.  
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Figure 2. Absolute Configurations of Chiral Non-racemic Tetrabenzoxazines and a Racemic 
Resorcinarene 
 
We were able to prepare tetracamphorsulfonate derivatives 8a-d and 8a’-d’ shown in Scheme 2, in 
high yields, from the tetraalkoxyresorcin[4]arenes 4a-d by heating them under reflux in pyridine with 
an excess of freshly prepared (S)-(+)-10-camphorsulfonyl chloride. Lower yields were obtained 
when using commercial (S)-(+)-10-camphorsulfonyl chloride. Separation of the 1:1 mixtures of 
diastereoisomers was achieved by chromatography on silica gel. However, we were only able to 
obtain a good recovery of the faster running diastereoisomer in some cases, possibly due to 
instability towards the isolation process in one isomer in each case. For example, using the 
resorcinarene 4a, although NMR spectra of the crude reaction mixtures indicated, as expected, that 
the diastereoisomers of the 2,8,14,20-tetra-n-propyl-4,10,16,22-tetracamphorsulfonyloxy-
6,12,18,24-tetramethoxyresorcin[4]arenes were formed as a 1:1 mixture, they were isolated in 46% 
and 23% yields. In one reaction using the resorcinarene 4b, we isolated a pair of diastereoisomeric 
tricamphorsulfonates in addition to the expected tetracamphorsulfonates. Thus, when we heated a 
solution of the resorcinarene 4b under reflux for 15 h in pyridine together with 12 equivalents of (S)-
(+)-10-camphorsulfonyl chloride we obtained a mixture of two tricamphorsulfonates 9b and 9b’ in 
22% yield together with the two tetracamphorsulfonates 8b and 8b’ in 28% yield. The 
tricamphorsulfonates were formed in a 1:4 ratio while the tetracamphorsulfonates were formed in a 
4:1 ratio as shown in Scheme 3. This suggests that there is increasing difficulty in the sequential 
addition of camphorsulfonyl residues to the hydroxy groups that results from steric problems that 
particularly affect the slower eluting diastereoisomer of the tricamphorsulfonate. That effect 
provides an explanation of the apparent diastereoselectivity in the latter reaction. Crystals of the first 
eluting diastereoisomers 8a and 8b were obtained that were suitable for X-ray crystallographic 
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analysis, and the crystal structures are shown in Figures 3 and 4. Because of potential confusion that 
has arisen in defining the absolute configuration of some C4 symmetric resorcin[4]arenes we 
introduced the convention of using the prefix (P)- or (M)- when defining the priority of substituents 
around an axis of chirality,6b by reference to the Cahn, Ingold, and Prelog convention,12a and 
subsequent discussions concerning axial chirality,12b,c,d together with Prelog and his co-workers’ 
discussion of a new kind of stereoisomerism, cycloenantiomerism and cyclodiastereomerism, that 
can be considered when the two directions in a cyclic structure can be distinguished.13 The crystal 
structures established that the two diastereoisomers were (M,S,R)-2,8,14,20-tetra-n-propyl-
4,10,16,22-tetracamphorsulfonyloxy-6,12,18,24-tetramethoxyresorcin[4]arene 8a and (M,S,R)-
2,8,14,20-tetra-n-pentyl-4,10,16,22-tetracamphorsulfonyloxy-6,12,18,24-
tetramethoxyresorcin[4]arene 8b.  
 
Racemic
4a, R1 = n-C3H7
4b, R1 = n-C5H11
4c, R1 = n-C7H15


























8a, R1 = n-C3H7
8b, R1 = n-C5H11
8c, R1 = n-C7H15
8d, R1 = n-C11H23
8a', R1 = n-C3H7
8b', R1 = n-C5H11
8c', R1 = n-C7H15
8d', R1 = n-C11H23











































8b, R1 = n-C5H11















































Figure 3. X-ray Structure of the Tetracamphorsulfonate (M,S,R)-8a; the hydrogen atoms are 
omitted for clarity. 
 
Figure 4. X-ray Structure of the Tetracamphorsulfonate (M,S,R)-8b; the hydrogen atoms are 
omitted for clarity. 
 
The influence of steric problems became even more evident when we studied the reactions of (S)-
(+)-10-camphorsulfonyl chloride with the tetraalkoxyresorcin[4]arenes 4e and 4f with bulkier head 
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groups. In a reaction in which 8 equivalents of freshly prepared (S)-(+)-10-camphorsulfonyl chloride, 
the tetraisopropyloxyresorcin[4]arene 4e, and DMAP were heated under reflux in pyridine, we were 
only able to obtain a mixture of diastereoisomeric monocamphorsulfonates in a combined yield of 
56%. The products 10e and 10e’, shown in Scheme 4, were separated by flash chromatography on 
silica gel after the prior separation from unchanged tetraisopropyloxyresorcin[4]arene 4e. In similar 
reactions, in which we omitted the DMAP, using the resorcinarenes 4e or 4f in pyridine, we obtained 
mixtures of two dicamphorsulfonates in a combined yield of 64% using 4e and in 46% yield using 4f. 
Although we do not have a crystal structure of any of the diastereoisomers of those 
dicamphorsulfonates, the steric problems noted above suggest that it is most likely that they are the 
distally substituted compounds 11e and 11f, and 11e’ and 11f’ shown in Scheme 5. We will return 
to this question below, in connection with reactions of anions generated using an excess of n-
butyllithium in tetrahydrofuran. 
 
Racemic
























   reflux, 15 h
O2S OR2 = 10e, R1 = n-C5H11 10e', R
1 = n-C5H11















4e, R1 = n-C5H11, R
2 = i-Pr

























 reflux, 15 h
O2S OR3 = 11e, R2 = i-Pr
11f, R2 = cyclopentyl











11e', R2 = i-Pr





We next turned our attention to deprotonation of the racemic tetraalkoxyresorcin[4]arenes using our 
previously disclosed deprotonation protocol,6a in which n-butyllithium in hexanes is added to a 
solution of an appropriate resorcin[4]arene derivative in anhydrous tetrahydrofuran at –78 °C. As 
well as allowing the possibility of preparing mono- and dicamphorsulfonates, we hoped to access 
some of the tetracamphorsulfonates in improved yields. In a reaction of the racemic 
tetramethoxyresorcin[4]arene 4b, the addition of 1.2 mol equivalents of n-butyllithium at –78 °C 
was followed, after 2 hours, by the addition of a THF solution of freshly prepared (S)-(+)-10-
camphorsulfonyl chloride (1.3 mol equivalents). After allowing the reaction mixture to warm to 
room temperature over 12 h, normal work up was followed by initial chromatographic separation of 
the reaction mixture on silica gel to give unchanged tetramethoxyresorcin[4]arene 4b together with 
mixtures of diastereoisomeric mono- and dicamphorsulfonates. Repeated chromatography of the 
mono- and dicamphorsulfonate mixtures allowed the isolation of a pair of monocamphorsulfonates 
each in 25% yield, together with a pair of dicamphorsulfonates each in 9% yield. In a reaction in 
which the amounts of n-butyllithium and (S)-(+)-10-camphorsulfonyl chloride were increased to 2.2 
and 2.3 mol equivalents respectively, we obtained the mono- and dicamphorsulfonates each in 33% 
yield, as shown in Scheme 6. Finally, the diastereoisomeric tetracamphorsulfonates were obtained in 
combined yields of 60% and 74% when reactions of the tetra-anion with freshly prepared (S)-(+)-10-
camphorsulfonyl chloride were carried out as shown in Scheme 7, in the first case initially at –78 °C 




























10b, R1 = n-C5H11 10b', R
1 = n-C5H11












11b, R1 = n-C5H11 11b', R
1 = n-C5H11
(i) n-BuLi, THF,
     –78 °C, 2 h
(ii)
(iii) then to RT
















































8b, R1 = n-C5H11 8b', R1 = n-C5H11
Scheme 7. The Formation of Tetracamphorsulfonates from a Tetra-anion
ClO2S O
(i) n-BuLi, THF,
    –78 °C to RT
(ii)
(iii) then to RT













Reactions of (S)-(+)-10-camphorsulfonyl chloride with anions derived from the racemic 
tetraisopropyloxy- and tetracyclopentyloxyresorcin[4]arenes 4e and 4f provided an interesting 
confirmation of the steric problems associated with the introduction of more than two 
camphorsulfonyl residues on the tetraalkoxyresorcin[4]arene scaffold. That we were able to prepare 
a tetra-anion from the tetraisopropyloxyresorcin[4]arene 4e was shown by the reaction with 
methoxymethyl chloride, which gave the racemate of the MOM ethers 12e in 46% yield, shown in 
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Scheme 8. This result may be compared to the analogous reaction using the 












Scheme 8. The Formation of Tetra(methoxymethyl)ethers from Tetra-anions
(i) n-BuLi (4.2 equiv.),















4b, R1 = n-C5H11, R
2 = Me
4e, R1 = n-C5H11, R
2 = i-Pr
12b, R1 = n-C5H11, R
2 = Me




Our initial reactions with anions derived from the racemic tetraisopropyloxy- and 
tetracyclopentyloxyresorcin[4]arenes 4e and 4f were carried out using 2.1 equivalents of n-
butyllithium and 2.1 equivalents of (S)-(+)-10-camphorsulfonyl chloride. In the case of the reactions 
using racemic 4e, we obtained the monocamphorsulfonates 10e and 10e’ in a combined yield of 48% 
together with a mixture of dicamphorsulfonates in 18% yield. Similarly, a reaction using the racemic 
4f gave the monocamphorsulfonates 10f and 10f’ in 46% yield together with the 
dicamphorsulfonates 11f and 11f’ in 22% yield. In view of the fact that we had found the more 
highly substituted derivatives easier to separate, we decided to attempt to prepare 
tetracamphorsulfonates from the resorcinarenes 4e and 4f. A reaction of the racemic 
tetraisopropyloxyresorcin[4]arene 4e with n-butyllithium (8 equivalents) at 0 °C followed by the 
addition of an excess of (S)-(+)-10-camphorsulfonyl chloride gave, however, a mixture of the 
diastereoisomeric dicamphorsulfonates 11e and 11e’ in a combined yield of 82%, as shown in 
Scheme 9. No trace of a tri- or tetracamphorsulfonate was detected. A similar reaction using the 
racemic compound 4f gave a mixture of the diastereoisomeric dicamphorsulfonates 11f and 11f’ in a 
combined yield of 56%, also shown in Scheme 9. We ascribe the failure to form 
tetracamphorsulfonates in these latter reactions to steric hindrance to the sulfonylation reaction that 




4e, R1 = n-C5H11, R
2 = i-Pr



































Scheme 9. The Formation of Dicamphorsulfonates from Tetra-anions
ClO2S O
(i) n-BuLi (8 equiv.), 
    THF, 0 °C
(ii)
(iii) then to RT
     12 h
(8 equiv.)
11e, R1 = n-C5H11, R
2 = i-Pr
11f, R1 = n-C5H11, R
2 = cyclopentyl
11e', R1 = n-C5H11, R
2 = i-Pr




Finally, we prepared the tetracamphorsulfonates 13a and 13a’ using (S)-(+)-10-camphorsulfonyl 
chloride [shown in Scheme 10] and 13b and 13b’ using freshly prepared (R)-(–)-10-
camphorsulfonyl chloride [shown in Scheme 11] from the racemic resorcin[4]arene 7 using the 
tetra-anion route. The structures of the tetracamphorsulfonates 13a and 13b were confirmed by the 


























Scheme 10. The Formation of Tetracamphorsulfonates from the Racemic Resorcinarene 7












(i) n-BuLi (8 equiv.), 
    THF, 0 °C
(ii)
(iii) then to RT
     12 h
(8 equiv.)





























Scheme 11. The Formation of Tetracamphorsulfonates from the Racemic Resorcinarene 7












(i) n-BuLi (8 equiv.), 
    THF, 0 °C
(ii)
(iii) then to RT
     12 h
(8 equiv.)







Figure 5. X-ray Structure of the Tetracamphorsulfonate (M,S,R)-13a; the hydrogen atoms are 







Figure 6. X-ray Structure of the Tetracamphorsulfonate (P,R,S)-13b; the hydrogen atoms are 
omitted for clarity. 
 
The structures of the various camphorsulfonates were established using a variety of analytical 
techniques in addition to X-ray crystallography.14 The number of camphorsulfonyl residues present 
in each of the products followed from high resolution (MALDI-TOF) mass spectrometric data in 
which the observed ion clusters in the molecular ion region matched the calculated intensities. 1H 
and 13C NMR data, in the case of the mono-, tri- and tetracamphorsulfonates, were unexceptional. 
The identification of the diastereoisomeric tetracamphorsulfonates was facilitated by inspection of 
the 1H NMR spectra. The difference in the chemical shifts of the two aromatic methine hydrogen 
atoms was ca. 0.08 ppm in the case of the first eluting diastereoisomer and ca. 0.17 ppm in the case 
of the second eluting diastereoisomer: illustrated for the compounds 8b and 8b’ in Figures 7 and 8. 
In the case of the dicamphorsulfonates two possible mixtures could have been formed. However, at 
present it has not been possible to obtain crystals that are suitable for X-ray analysis from any of the 
dicamphorsulfonates reported in this paper. Also, it was not possible to distinguish between the two 
possible regioisomers on the basis of NMR measurements carried out at different temperatures. The 
steric problems that we observed in the reactions of the racemic tetraisopropyloxy- and 
tetracyclopentyloxyresorcin[4]arenes 4e and 4f strongly support our suggestion that the 




Figure 7. The 1H NMR spectrum of Tetracamphorsulfonate (M,S,R)-8b 
 
Figure 8. The 1H NMR spectrum of Tetracamphorsulfonate (P,S,S)-8b’ 
 
We turned our attention next to the hydrolysis of the pure diastereoisomeric camphorsulfonates in 
order to obtain enantiomerically pure tetraalkoxyresorcin[4]arenes. Hydrolysis of the 
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camphorsulfonates was achieved by heating aqueous alcoholic sodium hydroxide solutions under 
reflux. The results, illustrated for the first eluting diastereoisomer derived from (S)-(+)-10-
camphorsulfonyl chloride, are shown for the hydrolyses of the tetracamphorsulfonates in Scheme 
12, and for the hydrolyses of the dicamphorsulfonates in Scheme 13. The most important conclusion 
that emerged from those reactions is that, as expected, the hydrolyses of each of the first eluting 
diastereoisomers derived from reactions using (S)-(+)-10-camphorsulfonyl chloride gave 
enantiomerically pure tetraalkoxyresorcin[4]arenes that each had specific rotations with the same 
sign: in the case of the first eluting diastereoisomers a (+)-specific rotation. The hydrolysis of the 
second eluting diastereoisomer in each case gave the (–)-enantiomer; for example 13a’ gave (M,R)-
(–)-7. In the case of the hydrolysis of the diastereoisomers 13b and 13b’ that were obtained using 
(R)-(–)-10-camphorsulfonyl chloride hydrolysis of the first eluting diastereoisomer gave, as 
anticipated, the enantiomer (M,R)-(–)-7, shown in Scheme 14, and the second eluting 













8a,   R1 = n-C3H7
8b,   R1 = n-C5H11
8c,   R1 = n-C7H15
8d,   R1 = n-C11H23
13a, R1 = 2-methylpropyl
Scheme 12. Hydrolyses of the First Eluting Tetracamphorsulfonates Derived from











(P,S)-(+)-4a, R1 = n-C3H7
(P,S)-(+)-4b, R1 = n-C5H11
(P,S)-(+)-4c, R1 = n-C7H15
(P,S)-(+)-4d, R1 = n-C11H23
(P,S)-(+)-7, R1 = 2-methylpropyl
NaOH, EtOH/H2O














11e, R1 = n-C5H11, R
2 = i-Pr




Scheme 13. Hydrolyses of the First Eluting Dicamphorsulfonates Derived from












    reflux, 36 h
(P,S)-(+)-4e, R1 = n-C5H11, R
2 = i-Pr

















13b,  R1 = 2-methylpropyl
P
O
Scheme 14. Hydrolysis of the First Eluting Tetracamphorsulfonate Derived from
                    (R)-(–)-10-Camphorsulfonyl chloride
NaOH, EtOH/H2O












(M,R)-(–)-7, R1 = 2-methylpropyl
 
 
We had available, as an additional confirmation of the absolute configurations of some of the chiral 
non-racemic tetraalkoxyresorcinarenes, the possibility of comparing NMR data for some 
tetrabenzoxazine derivatives, which we had obtained from reactions of tetraalkoxyresorcinarenes 
with chiral non-racemic N,N-bis(methoxymethyl)-N-α-methylbenzylamine derivatives.6b The 
compound 14 was prepared from (P,S)-(+)-4b using (S)-(–)-N,N-bis(methoxymethyl)-N-α-
methylbenzylamine in 46% yield; its absolute configuration was known from an earlier study.6a The 
structures of the diastereoisomers (P,R,S)-5 and (M,S,R)-6 were known from the results of X-ray 
structure determinations.6b We prepared compound (P,R,S)-5 and compound (M,R,R)-6’, the 
diastereoisomer of compound (M,S,R)-6, from (M,R)-(–)-4f in 58% yield and (P,S)-(+)-4e in 53% 
yield respectively using (R)-(+)-N,N-bis(methoxymethyl)-N-α-methylbenzylamine. These 
experiments also confirmed the assignments of the absolute configurations of enantiomerically pure 
tetraalkoxyresorcin[4]arenes. In the case of the racemic tetramethoxyresorcin[4]arene 7, we 
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prepared the diastereoisomeric tetrabenzoxazines using the microwave enhanced method, shown in 
Scheme 15. Separation of the diastereoisomers gave compounds whose NMR spectra could be 
compared with compounds that had been obtained previously.6b We also prepared the 
diastereoisomer 15a from the chiral non-racemic tetramethoxyresorcin[4]arene (P,S)-(+)-7 using the 
microwave enhanced method. The spectra confirmed the anticipated structure as 15a for the first 
eluting diastereoisomer and 15b for the second eluting diastereoisomer and as a result provided 
additional confirmation of the structures of the enantiomeric tetramethoxyresorcin[4]arenes (P,S)-
























(M,S,R)-14, R = n-C5H11
M








































































































Scheme 15 The Synthesis of Tetrabenzoxazines from Racemic 





In this study we have shown that it is possible to prepare and isolate diastereoisomeric mono-, di-, 
tri-, and tetracamphorsulfonates from a range of tetraalkoxyresorcin[4]arenes. The absolute 
 22 
configurations of the diastereoisomers were established by a combination of X-ray crystallographic 
and NMR spectroscopic studies. Hydrolysis of the single diastereoisomeric camphorsulfonates gave 
a series of tetraalkoxyresorcin[4]arenes in which the (+)-rotatory enantiomers were shown to be of 
(P,S)- chirality and the (–)-rotatory enantiomers were of (M,R)- chirality. Further confirmation of 
the absolute stereochemistry of the tetramethoxyresorcin[4]arene (P,S)-(+)-7 was provided by its 
conversion into the tetrabenzoxazine derivative 15a. These results correct the assignment of the 
absolute stereochemistry of the tetramethoxyresorcin[4]arene (+)-7 and also of (–)-7: also the 
absolute stereochemistries of diastereoisomeric tetra-2-methylbutyloxy- ethers derived from the 
compounds (P,S)-(+)-7 and (M,R)-(–)-7 and a pair of diastereoisomeric tetra-2-
methylbutyloxyresorcin[4]arenes that were reported in the earlier study.9 
 23 
Experimental Section 
General Experimental Detail. All infrared spectra were obtained using a Perkin-Elmer Paragon 
1000 FT-IR and a Bruker Vector 22 FTIR spectrophotometers; thin film spectra were acquired 
using sodium chloride plates. All 1H and 13C NMR spectra were measured at 400.13 and 100.62 
MHz with a Bruker DPX 400 / Avance 400 MHz spectrometer, in deuteriochloroform solution 
unless otherwise stated, using TMS (tetramethylsilane) as the internal reference. Mass spectra were 
recorded using a Jeol-SX102 instrument utilizing electron-impact (EI), fast atom bombardment 
(FAB), and by the EPSRC national mass spectrometry service at the University of Wales, Swansea, 
utilizing electrospray (ES) and MALDI-TOF. Analysis by GCMS utilized a Fisons GC 8000 series 
(AS 800), using a 15 m x 0.25 mm DB-5 column and an electron-impact low resolution mass 
spectrometer. Melting points were recorded using an Electrothermal-IA 9100 melting point 
instrument and are uncorrected. Optical rotation values were measured with an Optical Activity-
polAAar 2001 instrument and a Perkin-Elmer 141 polarimeter, operating at λ=589 nm, 
corresponding to the sodium D line, at the temperatures indicated. Microanalyses were performed on 
a Perkin Elmer Elemental Analyser 2400 CHN. All chromatographic manipulations used silica gel as 
the adsorbent. Reactions were monitored using thin layer chromatography (TLC) on aluminium-
backed plates coated with Merck Kieselgel 60 F254 silica gel. TLC plates were visualized by UV 
radiation at a wavelength of 254 nm, or stained by exposure to an ethanolic solution of 
phosphomolybdic acid (acidified with concentrated sulfuric acid), followed by charring where 
appropriate. Reactions requiring anhydrous conditions were carried out using flame dried glassware 
under a nitrogen atmosphere unless otherwise stated. Reaction solvents were used as obtained 
commercially unless otherwise stated. Light petroleum (b.p. 40-60 ºC) was distilled from calcium 
chloride prior to use. Ethyl acetate was distilled over calcium sulfate or chloride. Dichloromethane 
was distilled over calcium hydride. Tetrahydrofuran was distilled under a nitrogen atmosphere from 
the sodium/benzophenone ketyl radical. Microwave reactions were carried out in a CEM Discover 
focused microwave set at a maximum of 300 W. 
 
General procedure 1: 
The corresponding resorcinarene was dissolved in dry pyridine (10 mL) under a nitrogen atmosphere 
and (S)-(+)-camphorsulfonyl chloride added in several portions at room temperature. The mixture 
was then heated under reflux overnight. The bulk of the pyridine was removed at reduced pressure 
and the residue stirred with dilute hydrochloric acid (30 mL) for 30 minutes. The mixture was then 
extracted with ether (2 x 30 mL) and the combined organic phases washed with dilute hydrochloric 
acid (2 x 30 mL), water (1 x 30 mL), brine (1 x 30 mL) and dried over anhydrous magnesium sulfate 
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(or anhydrous sodium sulfate). The ether was removed under reduced pressure to give a mixture of 
the desired compounds. 
 
General procedure 2: 
The corresponding resorcinarene was dissolved in tetrahydrofuran (50 mL) and the solution was 
cooled down to −78 °C (or 0 °C). n-Butyllithium (2.5M in hexanes) was slowly added to the 
solution and the reaction mixture was stirred for 30 minutes at −78 °C (or 0 °C). A solution of a 
camphorsulfonyl chloride in tetrahydrofuran (10 mL) was then slowly added using a cannula to the 
reaction mixture. The mixture was allowed to warm to room temperature and was stirred for 12 
hours. A solution of hydrochloric acid (3.5 M) was then added to bring the pH below 7 and the 
phases were separated. The aqueous phase was then extracted with diethyl ether (3 x 25 mL). The 
combined organic phases were washed with brine, dried over anhydrous magnesium sulfate (or 
anhydrous sodium sulfate) and concentrated under reduced pressure to give a mixture of the desired 
compounds. 
 
General procedure 3: 
The corresponding resorcinarene was dissolved in methanol or ethanol (10 mL). Water (1 mL) and 
sodium hydroxide were added, and the mixture was heated under reflux overnight. The solvent was 
removed under reduced pressure. Water (approx. 10 mL) was then added to the residue. The pH of 
the mixture was then adjusted to pH 2 with hydrochloric acid (conc.) and the acidified mixture 
extracted with dichloromethane (2 x 10 mL). The combined organic phases were dried over 




tetramethoxyresorcin[4]arene (M,S,R)-8a and (P,S,S)-8a’: 
 
Using general procedure 1: 
General procedure 1 followed using 2,8,14,20-tetrapropyl-6,12,18,24-
tetramethoxyresorcin[4]arene 4a6b (2.00 g, 2.8 mmol) and (S)-(+)-camphorsulfonyl chloride (5.63 g, 
22.5 mmol) to give the diastereoisomeric mixture which was placed on a column of silica gel and 
eluted with CH2Cl2/EtOAc (93:7). The resulting glassy solids were crystallized from methanol to 
give: 
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Compound (M,S,R)-8a: as colourless crystals (2.02 g, 46%). M.p. 189-191 °C (Softens 165 °C). 
[α]D25 +61.3 (c 6.2). νmax (CHCl3)/cm-1 2958, 2873, 1748, 1498, 1357; δH (400 MHz, CDCl3) 0.90 
(12 H, s), 0.95 (12 H, t, J 7.4 Hz), 1.14 (12 H, s), 1.30-1.50 (12 H, m), 1.65-1.75 (4 H, m), 1.79-
1.90 (8 H, m), 1.97 (4 H, d, J 18.8 Hz), 2.01-2.16 (8 H, m), 2.38-2.57 (8 H, m), 3.26 and 3.84 (8 H, 
AB, J 14.8 Hz), 3.67 (12 H, s), 4.52 (4 H, t, J 7.4 Hz), 6.73 (4 H, s), 6.80 (4 H, s); δC (100 MHz, 
CDCl3) 14.9, 20.4, 20.6, 21.7, 25.8, 27.6, 36.4, 37.7, 43.2, 43.6, 48.5, 49.1, 56.6, 58.8, 105.4, 
126.9, 129.0, 131.7, 146.4, 156.1, 214.7.  
Compound (P,S,S)-8a’: as a glassy solid (1.02 g, 23%). [α]D25 +2.6 (c 4.2). νmax (CHCl3)/cm-1 
2957, 2872, 1749, 1498, 1357; δH (400 MHz, CDCl3) 0.92-0.96 (24 H, m), 1.17 (12 H, s), 1.30-
1.51 (12 H, m), 1.61-1.71 (4 H, m), 1.79-1.88 (8 H, m), 1.97 (4 H, d, J 18.4 Hz), 2.00-2.16 (8 H, 
m), 2.37-2.56 (8 H, m), 3.26 and 3.85 (8 H, AB, J 15.0 Hz), 3.70 (12 H, s), 4.50 (4 H, t, J 7.3 Hz), 
6.68 (4 H, s), 6.83 (4 H, s); δC (100 MHz, CDCl3) 14.9, 20.4, 20.7, 21.7, 25.8, 27.6, 36.6, 37.5, 




tetramethoxyresorcin[4]arene (M,S,R)-8b and (P,S,S)-8b’ and 2,8,14,20-tetrapentyl-4,10,16-
tri-(S)-camphorsulfonyloxy-22-hydroxy-6,12,18,24-tetramethoxyresorcin[4]arene 9b and 9b’: 
 
Using general procedure 1: 
General procedure 1 followed using 22,8,14,20-tetrapentyl-6,12,18,24-
tetramethoxyresorcin[4]arene 4b (0.20 g, 0.24 mmol) and (S)-(+)-camphorsulfonyl chloride (0.72 g, 
2.88 mmol) to give the diastereoisomeric mixture which was placed on a column of silica gel and 
eluted with CH2Cl2/Et2O (96:4) to give: 
Compound (M,S,R)-8b: as a colourless foam (0.095 g, 23%). [α]D25 +41.8 (c 1.1, CHCl3). νmax 
(DCM)/cm-1 2955, 2929, 2858, 1747, 1497, 1455, 1356, 1193, 1129, 1068, 1053, 831 and 810; δH 
(400 MHz, CDCl3) 0.85 (12 H, t, J 7.0 Hz), 0.89 (12 H, s), 1.12 (12 H, s), 1.24-1.35 (24 H, m), 
1.44 (4 H, ddd, J 12.7, 9.3, 3.8 Hz), 1.68 (4 H, ddd, J 14.0, 9.3 , 4.3 Hz), 1.79-1.86 (8 H, m), 1.99 
(4 H, d, J 18.4 Hz), 2.03-2.13 (8 H, m), 2.41 (4 H, dt, J 9.3, 3.8 Hz), 2.51 (4 H, ddd, J 14.0, 11.9, 
4.3 Hz), 3.24 and 3.82 (8 H, AB, J 15.0 Hz), 3.65 (12 H, s), 4.48 (4 H, t, J 7.3 Hz), 6.69 (4 H, s), 
6.78 (4 H, s); δC (100 MHz, CDCl3) 14.2, 19.7, 19.9, 22.6, 25.1, 26.9, 27.7, 32.1, 34.7, 36.0, 42.5, 
42.9, 47.9, 48.5, 55.9, 58.1, 104.7, 126.2, 128.3, 131.1, 145.7, 155.4, 214.0; m/z (FAB): 
1681.7935; [C92H128O20S4+H]
+
 requires 1681.7960. 
 26 
Compound (P,S,S)-8b’: as a colourless foam (0.023 g, 5.5%). [α]D25 +12.3 (c 1.2, CHCl3). νmax 
(DCM)/cm-1 2954, 2928, 2856, 1747, 1613, 1582, 1496, 1356, 1277, 1193, 1179, 1067, 1053, 832 
and 810; δH (400 MHz, CDCl3) 0.85 (12 H, t, J 7.0 Hz), 0.93 (12 H, s), 1.16 (12 H, s), 1.25-1.36 
(24 H, m), 1.38-1.49 (4 H, m), 1.65 (4 H, ddd, J 14.0, 9.2, 4.4 Hz), 1.79-1.85 (8 H, m), 1.97 (4 H, 
d, J 18.4 Hz), 2.01-2.17 (8 H, m), 2.41 (4 H, dt, J 9.3, 3.6 Hz), 2.46 (4 H, ddd, J 14.0, 12.0, 3.8 
Hz), 3.25 and 3.85 (8 H, AB, J 14.8 Hz), 3.70 (12 H, s), 4.47 (4 H, t, J 7.2 Hz), 6.66 (4 H, s), 6.82 
(4 H, s); δC (100 MHz, CDCl3) 14.1, 19.7, 20.0, 22.6, 25.1, 26.9, 27.7, 32.0, 34.6, 36.2, 42.4, 43.0, 
47.8, 48.6, 55.9, 58.1, 104.8, 126.2, 128.2, 130.9, 145.8, 155.5, 213.8; m/z (MALDI-TOF): 1704.8 
[M+Na]+; the isotopic distribution of the observed data matched the theoretical [M+Na]+ isotopic 
distribution. 
Compound 9b: as a colourless foam (0.017 g, 4.8%). [α]D25 +34.4 (c 1.0, CHCl3). νmax (DCM)/cm-
1 3478, 2956, 2927, 2855, 1746, 1495, 1356, 1262, 1193, 1179, 1068, 1053, 1022, 809; δH (400 
MHz, CDCl3) 0.84 (12 H, m), 0.89 (3 H, s), 0.91 (3 H, s), 1.15 (3 H, s), 1.16 (3 H, s), 1.18 (3 H, s), 
1.23 (3 H, s), 1.38-1.27 (24 H, m), 1.46 (1 H, m), 1.78-1.60 (3 H, m), 2.00-1.82 (11 H, m), 2.18-
2.02 (6 H, m), 2.61-2.39 (6 H, m), 3.22 and 3.87 (2 H, AB, J 14.8 Hz), 3.25 and 3.89 (2 H, AB, J 
14.8 Hz), 3.32 and 3.77 (2 H, AB, J 14.8 Hz), 3.60 (3 H, s), 3.66 (3 H, s), 3.74 (3 H, s), 3.86 (3 H, 
s), 4.24 (1 H, t, J 7.1 Hz), 4.57 (3 H, m), 6.27 (1 H, s), 6.75 (1 H, s), 6.78 (1 H, s), 6.85 (1 H, s), 
6.89 (1 H, s), 6.90 (1 H, s), 6.92 (1 H, s), 7.06 (1 H, s); δC (100 MHz, CDCl3) 14.1, 19.8, 19.9, 
20.0, 22.4, 22.5, 22.6, 22.7, 25.1, 25.2, 26.8, 27.4, 27.5, 27.6, 27.7, 29.7, 31.9, 32.0, 32.1, 34.3, 
34.7, 35.1, 35.2, 35.3, 35.5, 35.8, 42.5, 42.8, 42.9, 47.8, 47.9, 48.1, 48.2, 48.3, 55.7, 55.8, 55.9, 
56.1, 58.1, 58.2, 99.8, 104.3, 104.4, 104.8, 120.9, 123.9, 125.1, 125.7, 126.1, 126.8, 127.9, 129.7, 
129.9, 130.5, 131.1, 131.5, 145.6, 145.8, 146.0, 152.6, 154.1, 155.1, 155.5, 156.4, 214.1; m/z 
(MALDI-TOF): 1490.7 [M+Na]+; the isotopic distribution of the observed data matched the 
theoretical [M+Na]+ isotopic distribution. 
Compound 9b’: as a colourless foam (0.065 g, 18%). [α]D25 −46.7 (c 1.2, CHCl3). νmax (DCM)/cm-
1 3482, 2954, 2928, 2857, 1748, 1496, 1356, 1278, 1194, 1179, 1067, 1053, 832, 811; δH (400 
MHz, CDCl3) 0.85 (12 H, m), 0.86 (3 H, s), 0.91 (3 H, s), 0.92 (3 H, s), 1.14 (3 H, s), 1.17 (3 H, s), 
1.18 (3 H, s), 1.36-1.25 (24 H, m), 1.45 (3 H, m), 1.61 (1 H, m), 1.73 (2 H, m), 2.00-1.86 (11 H, 
m), 2.14-2.04 (6 H, m), 2.58-2.38 (6 H, m), 3.21 and 3.78 (2 H, AB, J 14.9 Hz), 3.29 and 3.89 (2 
H, AB, J 14.9 Hz), 3.29 and 3.93 (2 H, AB, J 14.9 Hz), 3.61 (3 H, s), 3.65 (3 H, s), 3.79 (3 H, s), 
3.86 (3 H, s), 4.24 (1 H, t, J 7.2 Hz), 4.52 (2 H, m), 4.59 (1 H, t, J 7.1 Hz), 6.26 (1 H, s), 6.67 (1 
H, s), 6.79 (1 H, s), 6.80 (1 H, s), 6.91 (1 H, s), 6.93 (1 H, s), 6.94 (1 H, s), 7.07 (1 H, s); δC (100 
MHz, CDCl3) 14.1, 19.7, 19.9, 20.1, 22.5, 22.6, 22.7, 25.1, 25.2, 25.3, 26.8, 26.9, 27.4, 27.5, 27.6, 
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27.7, 31.9, 32.0, 32.1, 34.5, 34.9, 35.2, 35.4, 35.6, 42.4, 42.5, 42.9, 43.0, 47.8, 47.9, 48.3, 48.4, 
48.5, 55.6, 55.8, 55.9, 56.1, 58.1, 99.7, 104.3, 104.4, 105.0, 120.5, 123.5, 125.0, 125.7, 126.0, 
126.8, 127.6, 129.6, 129.8, 130.1, 131.1, 131.6, 145.6, 145.7, 146.0, 152.7, 154.2, 154.9, 155.6, 
156.4, 214.1; m/z (MALDI-TOF): 1490.7 [M+Na]+; the isotopic distribution of the observed data 
matched the theoretical [M+Na]+ isotopic distribution. 
 
Using general procedure 2: 
General procedure 2 followed using 2,8,14,20-tetrapentyl-6,12,18,24-
tetramethoxyresorcin[4]arene 4b (1.0 g, 1.2 mmol), n-butyllithium (2.5M in hexanes, 4.9 mL, 9.7 
mmol) and (S)-(+)-camphorsulfonyl chloride (3.0 g, 12.1 mmol) at 0 °C to give the 
diastereoisomeric mixture which was placed on a column of silica gel and eluted with CH2Cl2/Et2O 
(96:4) to give compound (M,S,R)-8b (0.683 g, 33%) and compound (P,S,S)-8b’ (0.675 g, 33%). 
 
2,8,14,20-Tetraheptyl-4,10,16,22-tetra-(S)-camphorsulfonyloxy-6,12,18,24-
tetramethoxyresorcin[4]arene (M,S,R)-8c and (P,S,S)-8c’: 
 
Using general procedure 1: 
General procedure 1 followed using 2,8,14,20-tetraheptyl-6,12,18,24-
tetramethoxyresorcin[4]arene 4c (0.50 g, 0.53 mmol) and (S)-(+)-camphorsulfonyl chloride (1.07 g, 
4.3 mmol) to give the diastereoisomeric mixture which was placed on a column of silica gel and 
eluted with CH2Cl2/EtOAc (95:5) to give: 
Compound (M,S,R)-8c: as a colourless solid (0.38 g, 39%). [α]D25 +46.7 (c 4.1). νmax (DCM)/cm-1 
2928, 2856, 1749, 1498, 1358; δH (400 MHz, CDCl3) 0.86 (12 H, t, J 6.8 Hz), 0.90 (12 H, s), 1.13 
(12 H, s), 1.18-1.39 (40 H, m), 1.41-1.48 (4 H, m), 1.66-1.75 (4 H, m), 1.79-1.89 (8 H, m), 1.97 (4 
H, d, J 18.4 Hz), 2.02-2.16 (8 H, m), 2.38-2.57 (8 H, m), 3.26 and 3.84 (8 H, AB, J 14.8 Hz), 3.67 
(12 H, s), 4.49 (4 H, t, J 7.2 Hz), 6.71 (4 H, s), 6.80 (4 H, s); δC (100 MHz, CDCl3) 14.8, 20.4, 
20.6, 23.4, 25.8, 27.6, 28.7, 30.0, 30.6, 32.7, 35.5, 36.8, 43.2, 43.6, 48.5, 49.1, 56.6, 58.8, 105.4, 
126.9, 129.0, 131.8, 146.4, 156.1, 214.7. MS m/z 1793.9 (M+). 
Compound (P,S,S)-8c’: as a colourless solid (0.16 g, 17%). [α]D25 +5.6 (c 5.7). νmax (DCM)/cm-1 
2928, 2856, 1749, 1498, 1358; δH (400 MHz, CDCl3) 0.86 (12 H, t, J 6.7 Hz), 0.94 (12 H, s), 1.167 
(12 H, s), 1.17-1.38 (40 H, m), 1.40-1.56 (4 H, m), 1.60-1.70 (4 H, m), 1.77-1.88 (8 H, m), 1.97 (4 
H, d, J 18.4 Hz), 2.01-2.15 (8 H, m), 2.36-2.55 (8 H, m), 3.25 and 3.84 (8 H, AB, J 15.0 Hz), 3.70 
(12 H, s), 4.47 (4 H, t, J 7.3 Hz), 6.66 (4 H, s), 6.83 (4 H, s); δC (100 MHz, CDCl3) 14.8, 20.4, 
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20.7, 23.4, 25.8, 27.6, 28.7, 30.0, 30.5, 32.7, 35.3, 36.9, 43.1, 43.6, 48.5, 49.3, 56.5, 58.8, 105.5, 
126.9, 128.8, 131.6, 146.4, 156.1, 214.6. MS m/z 1793.9 (M+). 
 
2,8,14,20-Tetraundecyl-4,10,16,22-tetra-(S)-camphorsulfonyloxy-6,12,18,24-
tetramethoxyresorcin[4]arene (M,S,R)-8d and (P,S,S)-8d’: 
 
Using general procedure 1: 
General procedure 1 followed using 2,8,14,20-tetraundecyl-6,12,18,24-
tetramethoxyresorcin[4]arene 4d (0.50 g, 0.43 mmol) and (S)-(+)-camphorsulfonyl chloride (0.86 g, 
3.4 mmol) to give the diastereoisomeric mixture which was placed on a column of silica gel and 
eluted with CH2Cl2/EtOAc (93:7) to give:  
Compound (M,S,R)-8d: as a glassy solid (0.33 g, 38%). [α]D25 +51.4 (c 3.6). νmax (DCM)/cm-1 
2925, 2854, 1749, 1498, 1358; δH (400 MHz, CDCl3) 0.83-0.92 (24 H, m), 1.15 (12 H, m), 1.17-
1.37 (72 H, m), 1.40-1.50 (4 H, m), 1.65-1.75 (4 H, m), 1.78-1.90 (8 H, m), 1.97 (4 H, d, J 18.5 
Hz), 2.01-2.16 (8 H, m), 2.37-2.56 (8 H, m), 3.25 and 3.83 (8 H, AB, J 15.0 Hz), 3.66 (12 H, s), 
4.48 (4 H, t, J 7.2 Hz), 6.70 (4 H, s), 6.79 (4 H, s); δC (100 MHz, CDCl3) 14.8, 20.4, 20.6, 23.4, 
25.8, 27.6, 28.7, 30.1, 30.4, 30.5, 30.6, 30.7, 32.6, 35.5, 36.8, 43.2, 43.6, 48.5, 49.1, 56.6, 58.8, 
105.4, 126.9, 129.0, 131.8, 146.4, 156.1, 214.6. MS m/z 2018.0 (M+). 
Compound (P,S,S)-8d’: as a glassy solid (0.17 g, 20%). [α]D25 +0.14 (c 7.02). νmax (DCM)/cm-1 
2928, 2856, 1749, 1498, 1358; δH (400 MHz, CDCl3) 0.87 (12 H, t, J 6.5 Hz), 0.94 (12 H, s), 1.167 
(12 H, s), 1.17-1.37 (72 H, m), 1.38-1.50 (4 H, m), 1.60-1.71 (4 H, m), 1.76-1.87 (8 H, m), 1.97 (4 
H, d, J 18.5 Hz), 2.00-2.15 (8 H, m), 2.35-2.54 (8 H, m), 3.25 and 3.84 (8 H, AB, J 15.0 Hz), 3.70 
(12 H, s), 4.47 (4 H, t, J 7.2 Hz), 6.65 (4 H, s), 6.82 (4 H, s); δC (100 MHz, CDCl3) 14.8, 20.4, 
20.7, 23.4, 25.8, 27.6, 28.8, 30.1, 30.4, 30.5, 30.57, 30.64, 32.6, 35.3, 36.9, 43.1, 43.6, 48.5, 49.3, 
56.5, 58.8, 105.5, 126.9, 128.8, 131.6, 146.4, 156.1, 214.6; MS m/z 2018.3 (M+). 
 
2,8,14,20-Tetrapentyl-4-(S)-camphorsulfonyloxy-10,16,22-trihydroxy-6,12,18,24-
tetraisopropyloxyresorcin[4]arene 10e and 10e’ and 2,8,14,20-tetrapentyl-4,16-di-(S)-
camphorsulfonyloxy-10,22-dihydroxy-6,12,18,24-tetraisopropyloxyresorcin[4]arene 11e and 
11e’: 
 
Using general procedure 2: 
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General procedure 2 followed using 2,8,14,20-tetrapentyl-6,12,18,24-
tetraisopropopyloxyresorcin[4]arene 4e (1.0 g, 1.07 mmol), n-butyllithium (2.5M in hexanes, 0.86 
mL, 2.14 mmol) and (S)-(+)-camphorsulfonyl chloride (0.540 g, 2.14 mmol) at −78 °C to give the 
diastereoisomeric mixture which was placed on a column of silica gel and eluted with CH2Cl2/EtOAc 
(99:1) to give:  
Compound 10e: as a yellow foam (0.310 g, 25%). [α]D25 +60.0 (c 2.0, CHCl3). νmax (DCM)/cm-1 
3395, 2955, 2928, 2858, 1747, 1493, 1373, 1111, 846; δH (400 MHz, CDCl3) 0.84-0.91 (15 H, m), 
1.15 (3 H, s), 1.19-1.38 (31 H, m), 1.39-1.43 (18 H, m), 1.67-1.75 (1 H, m), 1.95 (1 H, d, J 18.5 
Hz), 2.07-2.23 (10 H, m), 2.40-2.47 (1 H, m), 2.56-2.64 (1 H, m), 3.25 and 3.80 (2 H, AB, J 14.9 
Hz), 4.22-4.32 (3 H, m), 4.38 (1 H, septet, J 6.1 Hz), 4.54-4.60 (2 H, m), 4.68-4.72 (2 H, m), 6.26 
(1 H, s), 6.32 (1 H, s), 6.40 (1 H, s), 6.87 (1 H, s), 7.14 (1 H, s), 7.21 (1 H, s), 7.24 (1 H, s), 7.25 (1 
H, s), 7.31 (1 H, s), 7.32 (1 H, s), 7.55 (1 H, s); δC (100 MHz, CDCl3) 14.1, 14.2, 19.7, 20.0, 21.6, 
21.8, 21.8, 21.9, 22.0, 22.03, 22.2, 22.6, 22.7, 22.74, 22.8, 25.2, 26.9, 27.5, 27.7, 27.8, 31.8, 32.0, 
32.1, 33.4, 33.5, 34.7, 42.5, 42.9, 47.9, 58.2, 70.0, 71.4, 71.7, 72.1, 101.6, 101.8, 102.7, 107.2, 
122.6, 122.6, 123.2, 123.4, 123.9, 124.1, 125.1, 125.6, 126.1, 128.1, 132.2, 132.4, 145.0, 150.8, 
151.4, 152.2, 152.4, 153.3, 214.02; m/z (MALDI-TOF): 1173.7 [M+Na]+; the isotopic distribution 
of the observed data matched the theoretical [M+Na]+ isotopic distribution. 
Compound 10e’: as a yellow foam (0.30 g, 24%). [α]D25 −31.3 (c 1.5, CHCl3). νmax (DCM)/cm-1 
3385, 2954, 2927, 2857, 2360 1747, 1493, 1373, 1111, 845; δH (400 MHz, CDCl3) 0.84-0.91 (15 
H, m), 1.14 (3 H, s), 1.19-1.43 (49 H, m), 1.70-1.79 (1 H, m), 1.97 (1 H, d, J 18.5 Hz), 2.07-2.22 
(10 H, m), 2.37-2.43 (1 H, m), 2.49-2.60 (1 H, m), 3.23 and 3.88 (2 H, AB, J 14.5 Hz), 4.24-4.33 
(3 H, m), 4.38 (1 H, septet, J 6.3 Hz), 4.50-4.60 (2 H, m), 4.64-4.72 (2 H, m), 6.26 (1 H, s), 6.32 (1 
H, s), 6.40 (1 H, s), 6.90 (1 H, s), 7.12 (1 H, s), 7.21 (1 H, s), 7.23 (1 H, s), 7.24 (1 H, s), 7.27 (1 
H, s), 7.33 (1 H, s), 7.57 (1 H, s); δC (100 MHz, CDCl3) 14.1, 14.2, 19.7, 19.9, 21.6, 21.7, 21.8, 
21.9, 22.0, 22.1, 22.2, 22.6, 22.68, 22.74, 22.8, 25.1, 26.9, 27.6, 27.75, 27.8, 31.8, 32.0, 32.1, 33.4, 
33.5, 34.7, 42.5, 42.9, 46.7, 47.9, 58.0, 70.1, 71.4, 71.7, 71.9, 101.6, 101.7, 102.7, 107.3, 122.5, 
122.6, 123.1, 123.4, 124.1, 125.4, 125.7, 126.1, 127.2, 132.0, 132.1, 145.1, 150.8, 151.4, 152.2, 
152.4, 153.3, 153.4, 154.6, 213.8; m/z (FAB): 1168.8 [M+NH4]
+; the isotopic distribution of the 
observed data matched the theoretical [M+NH4]
+ isotopic distribution. 
Compound 11e: as a colourless foam (0.120 g, 8%), [α]D25 +27.8 (c 1.2, CHCl3). νmax (DCM)/cm-1 
3500, 2954, 2928, 2857, 1748, 1494, 1372, 1189, 1114, 1053, 850; δH (400 MHz, CDCl3) 0.81-
0.92 (24 H, m), 1.01 (3 H, s), 1.17 (3 H, s), 1.23-1.44 (46 H, m), 1.59-1.67 (2 H, m), 1.70-2.14 (12 
H, m), 2.38-2.44 (3 H, m), 2.49-2.60 (1 H, m), 3.29 and 3.65 (2 H, AB, J 15.2 Hz), 3.34 and 3.84 
 30 
(2 H, AB, J 15.2 Hz), 4.20-4.32 (3 H, m), 4.51-4.61 (4 H, m), 4.75 (1 H, t, J 7.6 Hz), 6.22 (1 H, s), 
6.42 (1 H, s), 6.52 (1 H, s), 6.54 (1 H, s), 6.80 (1 H, s), 6.86 (1 H, s), 6.89 (1 H, s), 6.92 (1 H, s), 
7.08 (1 H, s), 7.33 (1 H, s); δC (100 MHz, CDCl3) 14.1, 14.1, 19.66, 19.74, 19.8, 20.0, 21.5, 21.7, 
21.8, 21.86, 21.87, 21.9, 22.18, 22.2, 22.57, 22.60, 22.61, 22.8, 25.1, 25.2, 26.8, 26.9, 27.5, 27.6, 
29.7, 31.9, 32.0, 32.2, 34.3, 34.5, 34.54, 34.8, 35.7, 36.2, 42.4, 42.5, 43.0, 47.6, 47.8, 48.1, 58.1, 
58.2, 69.9, 70.9, 71.5, 71.6, 101.9, 102.0, 107.2, 107.6, 114.5, 122.5, 123.5, 123.97, 124.0, 124.1, 
128.1, 125.8, 125.9, 126.5, 128.6, 130.9, 132.0, 133.0, 145.2, 146.1, 152.0, 152.2, 152.3, 152.8, 
152.9, 154.7, 214.0; m/z (MALDI-TOF): 1387.8 [M+Na]+; the isotopic distribution of the observed 
data matched the theoretical [M+Na]+ isotopic distribution. 
Compound 11e’: as a colourless foam (0.120 g, 8%). [α]D25 +11.2 (c 1.3, CHCl3). νmax (DCM)/cm-1 
3500, 2954, 2927, 2857, 1748, 1495, 1373, 1190, 1114, 1053, 850; δH (400 MHz, CDCl3) 0.81-
0.92 (24 H, m), 1.06 (3 H, s), 1.24 (3 H, s), 1.23-1.44 (46 H, m), 1.50-1.59 (1 H, m), 1.67-1.75 (1 
H, m), 1.77-2.14 (12 H, m), 2.34-2.43 (3 H, m), 2.52-2.64 (1 H, m), 3.12 and 3.68 (2 H, AB, J 14.7 
Hz), 3.25 and 3.93 (2 H, AB, J 14.7 Hz), 4.23-4.32 (3 H, m), 4.51-4.59 (4 H, m), 4.74 (1 H, t, J 7.6 
Hz), 6.23 (1 H, s), 6.42 (1 H, s), 6.49 (1 H, s), 6.50 (1 H, s), 6.81 (1 H, s), 6.90 (1 H, s), 6.91 (1 H, 
s), 6.93 (1 H, s), 7.06 (1 H, s), 7.32 (1 H, s); δC (100 MHz, CDCl3) 14.09, 14.1, 14.13, 19.7, 19.8, 
19.9, 20.0, 21.4, 21.7, 21.76, 21.8, 21.85, 21.9, 22.1, 22.2, 22.58, 22.59, 22.62, 22.8, 25.2, 25.6, 
26.8, 26.9, 27.4, 27.5, 28.0, 31.9, 31.94, 32.0, 32.2, 33.4, 34.3, 34.5, 35.7, 36.3, 42.4, 42.5, 43.0, 
43.2, 47.7, 47.76, 47.82, 48.3, 58.09, 58.11, 70.1, 70.9, 71.0, 71.4, 101.7, 102.0, 106.8, 107.1, 
114.5, 122.3, 123.9, 123.95, 124.0, 125.7, 125.9, 126.4, 128.4, 130.5, 131.9, 132.6, 145.0, 146.2, 
152.1, 152.2, 152.3, 152.8, 152.9, 154.7, 213.6, 213.9; m/z (MALDI-TOF): 1387.8 [M+Na]+; the 
isotopic distribution of the observed data matched the theoretical [M+Na]+ isotopic distribution. 
 
2,8,14,20-Tetrapentyl-4,16-di-(S)-camphorsulfonyloxy-10,22-dihydroxy-6,12,18,24-
tetraisopropyloxyresorcin[4]arene 11e and 11e’: 
 
Using general procedure 1: 
General procedure 1 followed using 2,8,14,20-tetrapentyl-6,12,18,24-
tetraisopropopyloxyresorcin[4]arene 4e (0.10 g, 0.11 mmol) and (S)-(+)-camphorsulfonyl chloride 
(0.43 g, 1.90 mmol) to give the diastereoisomeric mixture which was placed on a column of silica 
gel and eluted with CH2Cl2/EtOAc (96:4) to give compound 11e (0.049 g, 34%) and compound 
11e’ (0.044 g, 30%). 
 
Using general procedure 2: 
 31 
General procedure 2 followed using 2,8,14,20-tetrapentyl-6,12,18,24-
tetraisopropopyloxyresorcin[4]arene 4e (0.20 g, 0.21 mmol), n-butyllithium (2.5M in hexanes, 0.68 
mL, 1.71 mmol) and (S)-(+)-camphorsulfonyl chloride (0.54 g, 2.14 mmol) at 0 °C to give the 
diastereoisomeric mixture which was placed on a column of silica gel and eluted with CH2Cl2/EtOAc 
(98:2) to give compound 11e (0.13 g, 41%) and compound 11e’ (0.13 g, 41%). 
 
2,8,14,20-Tetrapentyl-4-(S)-camphorsulfonyloxy-10,16,22-trihydroxy-6,12,18,24-
tetracyclopentyloxyresorcin[4]arene 10f and 10f’and 2,8,14,20-tetrapentyl-4,16-di-(S)-
camphorsulfonyloxy-10,22-dihydroxy-6,12,18,24-tetracyclopentyloxyresorcin[4]arene 11f and 
11f’and: 
 
Using general procedure 2: 
General procedure 2 followed using 2,8,14,20-tetrapentyl-6,12,18,24-
tetracyclopentyloxyresorcin[4]arene 4f (1.0 g, 0.96 mmol), n-butyllithium (2.5M in hexanes, 0.76 
mL, 1.92 mmol) and (S)-(+)-camphorsulfonyl chloride (0.48 g, 1.92 mmol) at −78 °C to give the 
diastereoisomeric mixture which was placed on a column of silica gel and eluted with CH2Cl2 to 
give: 
Compound 10f: as a yellow foam (0.28 g, 23%). [α]D25 +26.7 (c 0.9, CHCl3). νmax (DCM)/cm-1 
3393, 2954, 2927, 1747, 1618, 1493, 1172; δH (400 MHz, CDCl3) 0.83-0.89 (12 H, m), 0.90 (3 H, 
s), 1.15 (3 H, s), 1.16-1.36 (24 H, m), 1.39-1.56 (2 H, m), 1.59-1.71 (9 H, m), 1.77-2.00 (25 H, m), 
2.08-2.19 (9 H, m), 2.38-2.44 (1 H, m), 2.54-2.61 (1 H, m), 3.21 and 3.80 (2 H, AB, J 14.8 Hz), 
4.19-4.28 (3 H, m), 4.54-4.63 (2 H, m), 4.72-4.75 (1 H, m), 4.84 (1 H, quintet, J 4.0 Hz), 4.93 (1 
H, quintet, J 2.8 Hz), 6.22 (1 H, s), 6.31 (1 H, s), 6.41 (1 H, s), 6.87 (1 H, s), 7.06 (1 H, s), 7.08 (1 
H, s), 7.12 (1 H, s), 7.17 (1 H, s), 7.22 (1 H, s), 7.32 (1 H, s), 7.42 (1 H, s); δC (100 MHz, CDCl3) 
14.1, 14.2, 19.7, 20.0, 22.6, 22.66, 22.7, 22.8, 23.7, 23.8, 23.83, 24.0, 24.1, 24.12, 24.4, 24.5, 25.3, 
27.4, 27.7, 27.8, 29.7, 31.6, 31.8, 31.9, 32.0, 32.3, 32.4, 32.5, 32.7, 32.8, 32.9, 32.9, 33.0, 33.2, 
33.24, 33.3, 33.5, 33.7, 34.6, 34.8, 35.8, 42.5, 42.9, 47.5, 47.8, 58.2, 79.0, 80.8, 80.9, 81.2, 101.2, 
101.6, 102.4, 106.7, 121.8, 122.1, 122.9, 123.2, 123.3, 124.8, 125.1, 125.4, 125.8, 127.4, 132.0, 
132.1, 144.9, 151.1, 151.6, 151.9, 152.9, 153.1, 153.2, 154.9, 214.0; m/z (MALDI-TOF): 1277.8 
[M+Na]+; the isotopic distribution of the observed data matched the theoretical [M+Na]+ isotopic 
distribution. 
Compound 10f’: as a yellow foam (0.27 g, 22%). [α]D25 +4.6 (c 1.3, CHCl3). νmax (DCM)/cm-1 
3393, 2953, 2928, 1747, 1583, 1493, 1169; δH (400 MHz, CDCl3) 0.83-0.92 (15 H, m), 1.15 (3 H, 
s), 1.16-1.36 (24 H, m), 1.39-1.56 (2 H, m), 1.59-2.00 (34 H, m), 2.09-2.21 (9 H, m), 2.39-2.43 (1 
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H, m), 2.48-2.59 (1 H, m), 3.21 and 3.86 (2 H, AB, J 14.5 Hz), 4.19-4.30 (3 H, m), 4.54-4.62 (2 H, 
m), 4.71-4.74 (1 H, m), 4.82 (1 H, quintet, J 4.1 Hz), 4.93 (1 H, m), 6.22 (1 H, s), 6.31 (1 H, s), 
6.42 (1 H, s), 6.89 (1 H, s), 7.06 (1 H, s), 7.07 (1 H, s), 7.09 (1 H, s), 7.16 (1 H, s), 7.22 (1 H, s), 
7.33 (1 H, s), 7.44 (1 H, s); δC (100 MHz, CDCl3) 14.1, 14.2, 19.7, 20.0, 22.6, 22.66, 22.74, 22.8, 
23.7, 23.8, 23.9, 24.0, 24.1, 24.2, 24.4, 24.5, 25.1, 26.9, 27.4, 27.6, 27.8, 31.6, 31.8, 31.9, 32.0, 
32.3, 32.4, 32.5, 32.7, 32.8, 32.9, 33.0, 33.1, 33.2, 33.5, 33.7, 34.6, 35.0, 36.0, 42.5, 42.9, 47.9, 
48.0, 58.0, 79.1, 80.8, 80.9, 81.1, 101.3, 101.6, 102.5, 106.7, 121.8, 122.1, 122.9, 123.2, 123.4, 
124.9, 125.0, 125.4, 125.8, 127.4, 131.8, 132.0, 144.5, 151.0, 151.5, 151.9, 152.9, 153.2, 153.3, 
155.0, 213.8; m/z (MALDI-TOF): 1277.8 [M+Na]+; the isotopic distribution of the observed data 
matched the theoretical [M+Na]+ isotopic distribution. 
Compound 11f: as a colourless foam (0.15 g, 10%), [α]D25 +25.7 (c 1.3, CHCl3). νmax (DCM)/cm-1 
3501, 2954, 2928 2869, 2358, 1748, 1493, 1454, 1357, 1171 and 832; δH (400 MHz, CDCl3) 0.77 
(3 H, s), 0.82-0.89 (12 H, m), 0.92 (3 H, s), 0.97 (3 H, s), 1.18 (3 H, s), 1.20-1.36 (24 H, m), 1.37-
1.56 (2 H, m), 1.59-2.19 (48 H, m), 2.33-2.45 (3 H, m), 2.55-2.63 (1 H, m), 3.14 and 3.61 (2 H, 
AB, J 14.9 Hz), 3.29 and 3.82 (2 H, AB, J 14.9 Hz), 4.17-4.25 (2 H, m), 4.47-4.54 (2 H, m), 4.70-
4.84 (4 H, m), 6.19 (1 H, s), 6.33 (1 H, s), 6.34 (1 H, m), 6.41 (1 H, s), 6.74 (1 H, s), 6.88 (3 H, s), 
7.05 (1 H, s) and 7.30 (1 H, s); δC (100 MHz, CDCl3) 14.1, 14.14, 19.6, 19.7, 19.8, 20.0, 22.58, 
22.6, 22.7, 23.9, 24.0, 24.10, 24.14, 24.2, 24.3, 25.2, 25.3, 26.8, 26.9, 27.4, 27.6, 27.9, 31.88, 31.9, 
32.0, 32.1, 32.3, 32.5, 32.6, 32.7, 32.8, 32.92, 33.1, 33.4, 34.3, 34.5, 35.8, 36.5, 42.4, 42.5, 43.0, 
47.4, 47.77, 47.8, 48.1, 58.1, 58.2, 78.9, 80.1, 80.8, 101.0, 101.6, 106.5, 106.8, 121.6, 123.2, 
123.7, 124.0, 125.5, 125.8, 125.9, 126.4, 128.2, 130.3, 131.4, 132.5, 145.2, 146.1, 152.0, 152.3, 
152.57, 152.6, 153.0, 154.9, 213.9, 217.1; m/z (MALDI-TOF): 1491.8 [M+Na]+; the isotopic 
distribution of the observed data matched the theoretical [M+Na]+ isotopic distribution. 
Compound 11f’: as a colourless foam (0.15 g, 10%), [α]D25 +5.8 (c 1.2, CHCl3). νmax (DCM)/cm-1 
3500, 2954, 2928, 2868, 1749, 1494, 1455, 1356, 1172, 1051 and 833; δH (400 MHz, CDCl3) 0.87 
(3 H, s), 0.90-0.96 (12 H, m), 0.97 (3 H, s), 1.11 (3 H, s), 1.23 (3 H, s), 1.25-1.37 (24 H, m), 1.39-
1.56 (2 H, m), 1.59-2.17 (47 H, m), 2.20 (1 H, t, J 4.3 Hz), 2.38-2.51 (3 H, m), 2.61-2.67 (1 H, m), 
3.14 and 3.61 (2 H, AB, J 14.9 Hz), 3.29 and 3.82 (2 H, AB, J 14.9 Hz), 4.17-4.25 (2 H, m), 4.47-
4.54 (2 H, m), 4.70-4.84 (4 H, m), 6.19 (1 H, s), 6.33 (1 H, s), 6.34 (1 H, m), 6.41 (1 H, s), 6.74 (1 
H, s), 6.88 (3 H, s), 7.05 (1 H, s), 7.30 (1 H, s); δC (100 MHz, CDCl3) 14.1, 14.14, 19.6, 19.7, 19.8, 
20.0, 22.58, 22.6, 22.7, 23.9, 24.0, 24.1, 24.14, 24.2, 24.3, 25.2, 25.3, 26.8, 26.9, 27.4, 27.6, 27.9, 
31.88, 31.9, 32.0, 32.1, 32.3, 32.5, 32.6, 32.7, 32.8, 32.9, 33.1, 33.4, 34.3, 34.5, 35.8, 36.5, 42.4, 
42.5, 43.0, 47.4, 47.7, 47.8, 48.1, 58.1, 58.2, 78.9, 80.1, 80.8, 101.0, 101.6, 106.6, 106.8, 121.6, 
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123.2, 123.7, 124.0, 125.5, 125.8, 125.9, 126.4, 128.2, 130.3, 131.4, 132.5, 145.2, 146.1, 152.0, 
152.3, 152.57, 152.6, 153.0, 154.9, 213.9, 217.1; m/z (MALDI-TOF): 1491.8 [M+Na]+; the isotopic 
distribution of the observed data matched the theoretical [M+Na]+ isotopic distribution. 
 
2,8,14,20-Tetrapentyl-4,16-di-(S)-camphorsulfonyloxy-10,22-dihydroxy-6,12,18,24-
tetracyclopentyloxyresorcin[4]arene 11f and 11f’: 
 
Using general procedure 1: 
General procedure 1 followed using 2,8,14,20-tetrapentyl-4,10,16,22-tetrahydroxy-6,12,18,24-
tetracyclopentyloxyresorcin[4]arene 4f (0.50 g, 0.48 mmol) and (S)-(+)-camphorsulfonyl chloride 
(1.44 g, 5.77 mmol) to give the diastereoisomeric mixture which was placed on a column of silica 
gel and eluted with CH2Cl2/EtOAc (98:2) to give compound 11f (0.16 g, 23%) and compound 11f’ 
(0.16 g, 23%). 
 
Using general procedure 2: 
General procedure 2 followed using 2,8,14,20-tetrapentyl-4,10,16,22-tetrahydroxy-6,12,18,24-
tetracyclopentyloxyresorcin[4]arene 4f (0.20 g, 0.19 mmol), n-butyllithium (2.5M in hexanes, 0.62 
mL, 1.54 mmol) and (S)-(+)-camphorsulfonyl chloride (0.48 g, 1.92 mmol) at 0 °C to give the 
diastereoisomeric mixture which was placed on a column of silica gel and eluted with CH2Cl2/EtOAc 
(99:1) to give compound 11f (0.08 g, 28%) and compound 11f’ (0.08 g, 28%). 
 
2,8,14,20-Tetrapentyl-4-(S)-camphorsulfonyloxy-10,16,22-trihydroxy-6,12,18,24-
tetramethoxyresorcin[4]arene 10b and 10b’ and 2,8,14,20-tetrapentyl-4,16-di-(S)-
camphorsulfonyloxy-10,22-dihydroxy-6,12,18,24-tetramethoxyresorcin[4]arene 11b and 11b’: 
 
Using general procedure 2: 
General procedure 2 followed using 2,8,14,20-tetrapentyl-4,10,16,22-tetrahydroxy-6,12,18,24-
tetramethoxyresorcin[4]arene 4b (0.20 g, 0.24 mmol), n-butyllithium (2.5M in hexanes, 0.12 mL, 
0.29 mmol) and (S)-(+)-camphorsulfonyl chloride (0.80 g, 0.31 mmol) at −78 °C to give the 
diastereoisomeric mixture which was placed on a column of silica gel and eluted with CH2Cl2/EtOAc 
(98:2) to give: 
Compound 10b: as a yellow foam (0.06 g, 25%). [α]D25 +48.8 (c 1.7, CHCl3). νmax (DCM)/cm-1 
3402, 2923, 2856, 1732, 1614, 1494, 1455, 1372, 1291, 1238, 1193, 1169, 902, 835, 810; δH (400 
MHz, CDCl3) 0.79 (12 H, t, J 7.2 Hz), 0.84 (3 H, s), 1.07 (3 H, s), 1.12-1.35 (24 H, m), 1.62 (1 H, 
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m), 1.98-2.10 (11 H, m), 2.35 (1 H, td, J 14.4, 4.2 Hz), 2.46 (1 H, m), 3.23 and 3.76 (2 H, AB, J 
15.0 Hz), 3.65 (3 H, s), 3.75 (6 H, s), 3.76 (3 H, s), 3.84 (3 H, s), 4.24 (3 H, m), 4.64 (1 H, t, J 7.1 
Hz), 6.23 (1 H, s), 6.27 (1 H, s), 6.28 (1 H, s), 7.05 (1 H, s), 7.06 (1 H, s), 7.11 (1 H, s), 7.12 (1 H, 
s), 7.13 (1 H, s), 7.18 (1 H, s), 7.20 (1 H, s), 7.25 (1 H, s); δC (100 MHz, CDCl3) 14.1, 19.7, 19.9, 
22.6, 22.7, 25.5, 26.8, 27.5, 27.6, 27.7, 31.8, 31.9, 32.0, 32.1, 33.1, 33.3,33.5, 34.2, 34.3, 35.7, 
42.5, 43.0, 47.7, 47.8, 55.7, 55.8, 56.3, 58.2, 99.8, 99.9, 104.6, 122.7, 123.6, 123.7, 123.9, 124.2, 
124.5, 124.7, 124.9, 126.1, 131.3, 131.8, 145.4, 152.5, 153.0, 153.1, 153.2, 153.7, 154.1, 156.1, 
214.1; m/z (MALDI-TOF): 1061.7 [M+Na]+; the isotopic distribution of the observed data matched 
the theoretical [M+Na]+ isotopic distribution. 
Compound 10b’: as a yellow foam (0.06 g, 25%). [α]D25 –27.6 (c 1.8, CHCl3). νmax (DCM)/cm-1 
3405, 2928, 2856, 1745, 1614, 1586, 1494, 1445, 1353, 1291, 1194, 903, 835, 809; δH (400 MHz, 
CDCl3) 0.70-0.84 (18 H, m), 1.18-1.28 (24 H, m), 1.66 (1 H, m), 1.89 (1 H, m), 1.97-2.08 (11 H, 
m), 2.30 (1 H, td, J 14.0, 4.0 Hz), 2.48 (1 H, m), 3.19 and 3.84 (2 H, AB, J 14.7 Hz), 3.66 (3 H, s), 
3.74 (3 H, s), 3.75 (3 H, s), 3.85 (3 H, s), 4.19 (3 H, m), 4.61 (1 H, t, J 7.2 Hz), 6.23 (1 H, s), 6.27 
(1 H, s), 6.28 (1 H, s), 6.85 (1 H, s), 7.12 (2 H, s), 7.13 (1 H, s), 7.18 (1 H, s), 7.20 (1 H, s), 7.24 (1 
H, s), 7.27 (1 H, s); δC (100 MHz, CDCl3) 14.1, 19.7, 19.9, 22.6, 22.7, 25.1, 26.9, 27.5, 27.7, 31.8, 
31.9, 32.0, 33.1, 33.3, 33.4, 34.0, 34.4, 35.8, 37.6, 42.6, 42.9, 47.7, 47.8, 55.6, 55.8, 56.3, 58.0, 
99.7, 99.9, 100.3, 104.4, 108.6, 122.7, 122.8, 123.6, 124.0, 124.1, 124.6, 124.7, 124.9, 126.2, 
131.1, 131.6, 145.1, 152.5, 153.0, 153.1, 153.2, 153.6, 154.1, 156.1, 214.0; m/z (FAB): 1061.7 
[M+Na]+; the isotopic distribution of the observed data matched the theoretical [M+Na]+ isotopic 
distribution. 
Compound 11b: as a yellow foam (0.027 g, 9%). [α]D25 −6.3 (c 1.0, CHCl3). νmax (DCM)/cm-1 
3468, 2928, 2856, 1746, 1615, 1585, 1495, 1463, 1356, 1290, 1193, 1067, 1053, 905, 831, 736; δH 
(400 MHz, CDCl3) 0.79 (12 H, m), 0.85 (3 H, s), 0.91 (3 H, s), 1.09 (3 H, s), 1.16 (3 H, s), 1.18-
1.38 (24 H, m), 1.44 (1 H, m), 1.62-1.74 (2 H, m), 1.80-1.98 (3 H, m), 2.04-2.16 (5 H, m), 2.38-
2.61 (3 H, m), 3.22 and 3.79 (2 H, AB, J 15.0 Hz), 3.32 and 3.86 (2 H, AB, J 15.0 Hz), 3.60 (3 H, 
s), 3.82 (6 H, s), 3.83 (3 H, s), 4.23 (2 H, m), 4.55 (1 H, t, J 6.7 Hz), 4.75 (1 H, t, J 7.7 Hz), 6.23 
(1 H, s), 6.41 (1 H, s), 6.86 (1 H, s), 6.89 (2 H, s), 6.99 (1 H, s), 7.11 (1 H, s), 7.36 (1 H, s); δC 
(100 MHz, CDCl3) 14.2, 19.8, 20.0, 20.1, 22.7, 25.4, 27.0, 27.5, 27.6, 27.7, 32.0, 32.1, 33.1, 34.0, 
34.3, 34.5, 36.1, 36.3, 42.6, 43.0, 47.7, 47.9, 48.2, 55.6, 56.0, 56.2, 58.2, 99.5, 100.1, 104.3, 104.9, 
121.9, 123.5, 123.8, 125.2, 125.4, 126.2, 129.3, 130.3, 131.2, 131.6, 145.7, 146.0, 152.5, 153.0, 
153.8, 153.9, 154.9, 156.5, 214.2; m/z (MALDI-TOF): 1275.6 [M+Na]+; the isotopic distribution of 
the observed data matched the theoretical [M+Na]+ isotopic distribution. 
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Compound 11b’: as a yellow foam (0.027 g, 9%). [α]D25 −10.4 (c 1.3, CHCl3). νmax (DCM)/cm-1 
3482, 2927, 2856, 1748, 1497, 1466, 1356, 1291, 1194, 1067, 905, 832; δH (400 MHz, CDCl3) 0.79 
(6 H, m), 0.80 (6 H, m), 0.82 (3 H, m), 0.84 (3 H, s), 1.06 (3 H, s), 1.10 (3 H, s), 1.12-1.30 (24 H, 
m), 1.39 (1 H, m), 1.50-1.60 (2 H, m), 1.69 (1 H, m), 1.87 (3 H, m), 2.15 (3 H, m), 2.37 (3 H, m), 
2.53 (1 H, m), 3.15 and 3.73 (2 H, AB, J 14.9 Hz), 3.22 and 3.88 (2 H, AB, J 14.9 Hz), 3.57 (3 H, 
s), 3.78 (6 H, s), 3.79 (3 H, s), 4.17 (2 H, m), 4.49 (1 H, t, J 7.0 Hz), 4.67 (1 H, t , J 7.8 Hz), 6.18 
(1 H, s), 6.35 (1 H, s), 6.60 (s1 H, s), 6.61 (1 H, s), 6.82 (1 H, s), 6.84 (1 H, s), 6.85 (1 H, s), 6.95 
(1 H, s), 7.04 (1 H, s), 7.29 (1 H, s); δC (100 MHz, CDCl3) 14.1, 19.7, 19.9, 20.0, 22.5, 22.6, 22.7, 
25.4, 25.5, 26.8, 26.9, 27.4, 27.5, 27.6, 27.7, 31.9, 32.0, 32.1, 33.1, 33.9, 34.2, 34.4, 36.0, 36.2, 
42.4, 42.5, 42.9, 43.1, 47.8, 47.9, 48.0, 48.2, 55.5, 56.0, 56.1, 56.2, 58.2, 99.4, 100.0, 104.3, 104.7, 
122.0, 123.3, 123.4, 123.7, 125.1, 125.2, 125.4, 126.0, 129.0, 130.1, 131.0, 131.4, 145.5, 145.9, 
152.5, 152.9, 153.8, 153.9, 154.9, 156.4, 214.1; m/z (MALDI-TOF): 1252.7 (M+); the isotopic 





2,8,14,20-Tetrapentyl-4,10,16,22-tetrahydroxy-6,12,18,24-tetramethoxyresorcin[4]arene 4b (0.50 
g, 0.6 mmol) was dissolved in tetrahydrofuran (20 mL) under nitrogen and the solution was cooled 
down to −78 °C. n-Butyllithium (2.5M in hexanes, 2.0 mL, 4.9 mmol) was slowly added to the 
solution and the reaction mixture was stirred for 30 minutes at −78 °C. Methoxymethyl chloride 
(370 µL, 4.9 mmol) was then added to the reaction mixture. The mixture was allowed to warm to 
room temperature and was stirred for 12 hours. Brine (20 mL) was then added and the phases were 
separated. The aqueous phase was then extracted with diethyl ether (3 x 10 mL). The combined 
organic phases were washed with brine, dried over anhydrous sodium sulfate and concentrated under 
reduced pressure. The residue was placed on a column of silica gel and eluted with EtOAc/hexane 
(15:85) to give compound 12b as a colourless foam (0.55 g, 90%). νmax (DCM)/cm-1 2924, 1610, 
1582, 1495, 1279, 1147, 731; δH (400 MHz, CDCl3) 0.87 (12 H, t, J 7.0 Hz), 1.22-1.39 (24 H, m), 
1.80-1.87 (8 H, m), 3.34 (12 H, s), 3.64 (120 H, s), 4.50 (4 H, t, J 7.6 Hz), 4.74 and 4.86 (8 H, AB, 
J 6.4 Hz), 6.51 (4 H, s), 6.66 (4 H, s); δC (100 MHz, CDCl3) 14.2, 22.7, 27.8, 32.2, 34.9, 35.5, 55.9, 










(0.35 g, 0.4 mmol) was dissolved in tetrahydrofuran (10 mL) under nitrogen and the solution was 
cooled down to 0 °C. n-Butyllithium (2.5M in hexanes, 0.9 mL, 2.2 mmol) was slowly added to the 
solution and the reaction mixture was stirred for 30 minutes at 0 °C. Methoxymethyl chloride (170 
µL, 2.2 mmol) was then added to the reaction mixture. The mixture was allowed to warm to room 
temperature and was stirred for 12 hours. Brine (20 mL) was then added and the phases were 
separated. The aqueous phase was then extracted with diethyl ether (3 x 10 mL). The combined 
organic phases were washed with brine, dried over anhydrous sodium sulfate and concentrated under 
reduced pressure. The residue was placed on a column of silica gel and eluted with EtOAc/hexane 
(20:80) to give compound 12e as a colourless foam (0.191 g, 46%). νmax (DCM)/cm-1 2953, 2928, 
2857, 1609, 1581, 1496, 1284, 1149, 1117, 1058, 1101; δH (400 MHz, CDCl3) 0.84 (12 H, t, J 6.9 
Hz), 0.94-1.03 (8 H, m), 1.19-1.41 (40 H, m), 1.74-1.85 (8 H, m), 3.38 (12 H, s), 4.34 (4 H, septet, 
J 5.3 Hz), 4.50 (4 H, t, J 7.5 Hz), 4.86 (8 H, m), 6.49 (4 H, s), 6.66 (4 H, s); δC (100 MHz, CDCl3) 
14.2, 21.8, 22.3, 22.7, 27.8, 32.1, 35.0, 35.4, 55.7, 69.8, 95.2, 101.6, 126.4, 128.2, 153.4, 153.5; 
m/z (FAB): 1113.7624 [M+H]+; [C68H104O12+H]
+
 requires 1113.7608. 
 
2,8,14,20-Tetra-(2-methylpropyl)-4,10,16,22-tetracamphorsulfonyloxy-6,12,18,24-
tetramethoxyresorcin[4]arene (M,S,R)-13a and (P,S,S)-13a’: 
 
Using general procedure 2: 
General procedure 2 followed using 2,8,14,20-tetra-(2-methylpropyl)-4,10,16,22-tetrahydroxy-
6,12,18,24-tetramethoxyresorcin[4]arene 7 (1.0 g, 1.3 mmol), n-butyllithium (2.5M in hexanes, 4.2 
mL, 10.4 mmol) and (S)-(+)-camphorsulfonyl chloride (2.6 g, 10.4 mmol) at 0 °C to give the 
diastereoisomeric mixture which was placed on a column of silica gel and eluted with CH2Cl2/EtOAc 
(97:3) to give: 
Compound (M,S,R)-13a: as colourless crystals (0.54 g, 26%). M.p.>248 °C (decomp.); [α]D25 
+43.3 (c 0.49, CHCl3); νmax (CHCl3) /cm-1 2954, 1748, 1611, 1496, 1366, 1178, 1073, 1005, 924, 
835; δH (400 MHz, CDCl3) 0.89 (12 H, s), 0.94 (12 H, d, J 6.0 Hz), 0.96 (12 H, d, J 6.0Hz), 1.12 
(12 H, s), 1.40-1.50 (4 H, ddd, J 4.0, 8.0, 13.5 Hz), 1.57-1.64 (4 H, m), 1.66-1.71 (12 H, m), 1.96 
(4 H, d, J 18.6 Hz), 2.01-2.10 (4 H, m), 2.13 (4 H, t, J 4.1 Hz), 2.36-2.53 (8 H, m), 3.26 and 3.84 
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(8 H, AB, J 15.2 Hz), 3.67 (12 H, s), 4.63 (4 H, t, J 6.8 Hz), 6.65 (4 H, s), 6.82 (4 H, s); δC (100 
MHz, CDCl3) 19.7, 19.9, 22.8, 22.9, 25.1, 25.8, 26.9, 33.9, 42.5, 42.9, 43.9, 47.9, 48.5, 55.9, 58.1, 
104.9, 126.4, 128.3, 131.0, 145.7, 155.4, 214.0; m/z (FAB): 1625.7352 [M+H]+; [C88H120O20S4+H]
+ 
requires 1625.7334. 
Compound (P,S,S)-13a’: as a colourless foam (0.51 g, 24%). [α]D25 +10.0 (c 1.2, CHCl3); νmax 
(DCM)/cm-1 2953, 1747, 1496, 1362, 1179, 1067, 924, 834; δH (400 MHz, CDCl3) 0.93 (24 H, t, J 
5.0 Hz), 0.95 (12 H, s), 1.16 (12 H, s), 1.42-1.48 (4 H, ddd, J 3.4, 9.2, 12.4 Hz), 1.56-1.66 (8 H, 
m), 1.71 (8 H, t, J 7.0 Hz), 1.96 (4 H, d, J 18.4 Hz), 2.02-2.09 (4 H, m), 2.12 (4 H, t, J 4.4 Hz), 
2.37-2.52 (8 H, m), 3.25 and 3.84 (8 H, AB, J 15.0 Hz), 3.71 (12 H, s), 4.61 (4 H, t, J 7.4 Hz), 6.59 
(4 H, s), 6.85 (4 H, s); δC (100 MHz, CDCl3) 19.7, 20.0, 22.76, 22.77, 25.1, 25.8, 26.9, 34.2, 42.4, 
43.0, 43.5, 47.8, 48.6, 55.9, 58.1, 104.9, 126.3, 128.1, 130.7, 145.9, 155.5, 213.8; m/z (FAB): 
1624.7234; [C88H120O20S4]
+ requires 1624.7256. 
 
2,8,14,20-Tetra-(2-methylpropyl)-4,10,16,22-tetracamphorsulfonyloxy-6,12,18,24-
tetramethoxyresorcin[4]arene (P,R,S)-13b and (M,R,R)-13b’: 
 
Using general procedure 2: 
General procedure 2 followed using 2,8,14,20-tetra-(2-methylpropyl)-4,10,16,22-tetrahydroxy-
6,12,18,24-tetramethoxyresorcin[4]arene 7 (1.0 g, 1.3 mmol), n-butyllithium (2.5M in hexanes, 4.2 
mL, 10.4 mmol) and (R)-(–)-camphorsulfonyl chloride (2.6 g, 10.4 mmol) at 0 °C to give the 
diastereoisomeric mixture which was placed on a column of silica gel and eluted with CH2Cl2/EtOAc 
(97:3) to give: 
Compound (P,R,S)-13b: as colourless crystals (0.76 g, 36%). [α]D25 −49.6 (c 1.1, CHCl3); νmax 
(CHCl3) /cm
-1 2955, 1747, 1612, 1496, 1366, 1180, 1067, 1005, 917, 835; δH (400 MHz, CDCl3) 
0.89 (12 H, s), 0.94 (12 H, d, J 6.0 Hz), 0.96 (12 H, d, J 6.0 Hz), 1.12 (12 H, s), 1.40-1.50 (4 H, 
ddd, J 4.0, 8.0, 13.5 Hz), 1.57-1.64 (4 H, m), 1.66-1.71 (12 H, m), 1.96 (4 H, d, J 18.4 Hz), 2.01-
2.10 (4 H, m), 2.13 (4 H, t, J 4.1 Hz), 2.36-2.53 (8 H, m), 3.26 and 3.83 (8 H, AB, J 14.8 Hz), 3.66 
(12 H, s), 4.63 (4 H, t, J 7.4 Hz), 6.64 (4 H, s), 6.82 (4 H, s); δC (100 MHz, CDCl3) 19.7, 19.9, 
22.8, 22.9, 25.1, 25.8, 26.9, 33.9, 42.5, 42.9, 43.9, 47.9, 48.5, 55.9, 58.1, 104.9, 126.4, 128.3, 
131.0, 145.7, 155.4, 214.0; m/z (FAB): 1624.7395 [M]+; [C88H120O20S4]
+ requires 1624.7256. 
Compound (M,R,R)-13b’: as a colourless foam (0.74 g, 35%). [α]D25 −12.8 (c 1.6, CHCl3); νmax 
(DCM)/cm-1 2955, 1747, 1497, 1367, 1179, 918, 836; δH (400 MHz, CDCl3) 0.92 (12 H, s, J 5.0 
Hz), 0.94 (24 H, d, J 6.4 Hz), 1.15 (12 H, s), 1.42-1.48 (4 H, ddd, J 3.4, 9.2, 12.4 Hz), 1.56-1.66 (8 
 38 
H, m), 1.71 (8 H, t, J 7.0 Hz), 1.96 (4 H, d, J 18.4 Hz), 2.02-2.09 (4 H, m), 2.12 (4 H, t, J 4.4 Hz), 
2.37-2.52 (8 H, m), 3.25 and 3.84 (8 H, AB, J 15.2 Hz), 3.70 (12 H, s), 4.60 (4 H, t, J 7.2 Hz), 6.59 
(4 H, s), 6.85 (4 H, s); δC (100 MHz, CDCl3) 19.7, 20.0, 22.76, 22.77, 25.1, 25.8, 26.9, 34.2, 42.4, 
43.0, 43.5, 47.8, 48.6, 55.9, 58.1, 104.9, 126.3, 128.1, 130.7, 145.9, 155.5, 213.8; m/z (FAB): 
1624.7480; [C88H120O20S4]





Using general procedure 3: 
General procedure 3 followed using (M,S,R)-8a (0.52 g, 0.33 mmol) and sodium hydroxide (1.32 
g, 33.1 mmol). The residue was crystallized from methanol to yield compound (P,S)-(+)-4a as pale 
orange plates (0.21 g, 89 %). M.p. 212-213 °C. [α]D25 +88.5 (c 2.6); δH (500 MHz, CDCl3) 0.99 (12 
H, t, J 7.4 Hz), 1.32 (8 H, hex, J 7.4 Hz), 2.20 (8 H, q, J 7.4 Hz), 3.84 (12 H, s), 4.31 (4 H, t, J 8.0 
Hz), 6.35 (4 H, s), 7.24 (4 H, s), 7.51 (4 H, s); δC (125 MHz, CDCl3) 14.7, 21.7, 33.4, 36.7, 56.6, 






Using general procedure 3: 
General procedure 3 followed using (P,S,S)-8a’ (0.16 g, 0.10 mmol) and sodium hydroxide (0.41 
g, 10.2 mmol). The residue was crystallized from methanol to yield compound (M,R)-(−)-4a as pale 
orange plates (0.057 g, 78 %), M.p. 212-213 °C. [α]D25 −89.2 (c 1.2). δH (500 MHz, CDCl3) 0.99 
(12 H, t, J 7.4 Hz), 1.32 (8 H, hex, J 7.2 Hz), 2.20 (8 H, q, J 7.2 Hz), 3.84 (12 H, s), 4.31 (4 H, t, J 
8.0 Hz), 6.35 (4 H, s), 7.24 (4 H, s), 7.50 (4 H, s); δC (125 MHz, CDCl3) 14.7, 21.7, 33.4, 36.7, 
56.6, 100.7, 124.5, 125.3, 125.4, 153.7, 154.4; Found: C, 72.7; H, 8.0; C44H56O8.CH3OH; requires 





Using general procedure 3: 
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General procedure 3 followed using 11b (0.1 g, 0.08 mmol) and sodium hydroxide (0.6 g, 15.0 
mmol). The residue was placed on a column of silica gel and eluted with CH2Cl2/EtOAc (98:2) to 
yield compound (P,S)-(+)-4b as a colourless foam (0.05 g, 70%). [α]D25 +52.5 (c 1.1, CHCl3); νmax 
(DCM)/cm-1 3403, 2927, 2856, 1619, 1588, 1495, 1464, 1335, 1293, 1239, 1196, 1166, 1089, 
1018, 901, 836; δH (400 MHz, CDCl3) 0.89 (12 H, t, J 7.0 Hz), 1.25-1.38 (24 H, m), 2.15-2.20 (8 
H, m), 3.83 (12 H, s), 4.26 (4 H, t, J 7.6 Hz), 6.34 (4 H, s), 7.21 (4 H, s), 7.52 (4 H, s); δC (100 
MHz, CDCl3) 13.1, 21.7, 26.8, 30.9, 32.1, 32.9, 54.8, 98.9, 122.6, 123.6, 123.7, 151.9, 152.6; m/z 
(FAB): 825.5306 [M+H]+; [C52H72O8+H]
+
 requires 825.5319. 
 
General procedure 3 followed using (M,S,R)-8b (0.4 g, 0.23 mmol) and sodium hydroxide (3.0 g, 
75 mmol). The residue was placed on a column of silica gel and eluted with CH2Cl2/EtOAc (98:2) to 





Using general procedure 3: 
General procedure 3 followed using 11b’ (0.1 g, 0.08 mmol) and sodium hydroxide (0.6 g, 15.0 
mmol). The residue was placed on a column of silica gel and eluted with CH2Cl2/EtOAc (98:2) to 
yield compound (M,R)-(−)-4b as a colourless foam (0.05 g, 70%). [α]D25 −51.6 (c 1.1, CHCl3). νmax 
(DCM)/cm-1 3403, 2927, 2856, 1619, 1588, 1495, 1464, 1335, 1293, 1239, 1196, 1166, 1089, 
1018, 901, 836; δH (400 MHz, CDCl3) 0.89 (12 H, t, J 7.0 Hz), 1.25-1.38 (24 H, m), 2.15-2.20 (8 
H, m), 3.83 (12 H, s), 4.26 (4 H, t, J 7.6 Hz), 6.34 (4 H, s), 7.21 (4 H, s), 7.52 (4 H, s); δC (100 




 requires 842.5565. 
 
General procedure 3 followed using (P,S,S)-8b’ (0.34 g, 0.20 mmol) and sodium hydroxide (2.5 g, 
62.5 mmol). The residue was placed on a column of silica gel and eluted with CH2Cl2/EtOAc (98:2) 






Using general procedure 3: 
General procedure 3 followed using (M,S,R)-8c (0.37 g, 0.2 mmol) and sodium hydroxide (1.6 g, 
40 mmol). The residue was crystallized from methanol to yield compound (P,S)-(+)-4c as colourless 
plates (0.16 g, 84%). M.p. 141.7–142.5 °C. [α]D25 +65.4 (c 1.3). δH (500 MHz, CDCl3) 0.90 (12 H, 
m), 1.20-1.42 (40 H, m), 2.10-2.28 (8 H, m), 3.84 (12 H, s), 4.27 (4 H, t, J 8.0 Hz), 6.35 (4 H, s), 
7.23 (4 H, s), 7.52, (4 H, s); δC (125 MHz, CDCl3) 14.8, 23.3, 28.8, 30.0, 30.3, 32.6, 33.8, 34.7, 
56.6, 100.7, 124.4, 125.3, 125.4, 153.7, 154.3; Found: C, 76.9; H, 9.6; C60H88O8; requires C, 76.9; 





Using general procedure 3: 
General procedure 3 followed using (P,S,S)-8c’ (0.32 g, 0.18 mmol) and sodium hydroxide (0.71 
g, 17.8 mmol). The residue was crystallized from methanol to yield compound (M,R)-(−)-4c as 
colourless plates (0.12 g, 70%). M.p. 140.6–141.8 °C. [α]D25 −66.1 (c 1.9). δH (500 MHz, CDCl3) 
0.90 (12 H, m), 1.17-1.46 (40 H, m), 2.10-2.28 (8 H, m), 3.84 (12 H, s), 4.27 (4 H, t, J 7.8 Hz), 
6.35 (4 H, s), 7.22 (s, 4 H), 7.54 (4 H, s); δC (125 MHz, CDCl3) 14.8, 23.3, 28.8, 30.0, 30.4, 32.6, 








Using general procedure 3: 
General procedure 3 followed using (M,S,R)-8d (0.11 g, 0.05 mmol) and sodium hydroxide (0.22 
g, 5.5 mmol). The residue was crystallized from methanol to yield compound (P,S)-(+)-4d as tan 
micro-crystals (0.05 g, 79%). M.p. 148.5-149.5 °C. [α]D25 +51.0 (c 1.3). δH (500 MHz, CDCl3) 0.89 
(12 H, m), 1.12-1.48 (72 H, m), 2.07-2.29 (8 H, m), 3.84 (12 H, s), 4.27 (4 H, t, J 7.4 Hz), 6.35 (4 
H, s), 7.22 (4 H, s), 7.53 (4 H, s); δC (125 MHz, CDCl3) 14.8, 23.4, 28.8, 30.1, 30.42, 30.44, 30.5, 
32.6, 33.8, 34.7, 56.6, 100.7, 124.4, 125.3, 125.4, 153.6, 154.3; Found: C, 77.9; H, 10.7; 






Using general procedure 3: 
General procedure 3 followed using (P,S,S)-8d’ (0.064 g, 0.03 mmol) and sodium hydroxide (0.15 
g, 3.8 mmol). The residue was crystallized from methanol to yield compound (M,R)-(−)-4d as pale 
orange waxy micro-crystals (0.022 g, 60%), M.p. 146.5-147.5 °C (softens 141-143). [α]D25 –46.9 (c 
1.0); δH (500 MHz, CDCl3) 0.90 (12 H, m), 1.22-1.42 (72 H, m), 2.16-2.23 (8 H, m), 3.84 (12 H, 
s), 4.28 (4 H, t, J 7.8 Hz), 6.35 (4 H, s), 7.22 (4 H, s), 7.52 (4 H, s); δC (125 MHz, CDCl3) 14.8, 






Using general procedure 3: 
General procedure 3 followed using 10e (0.09 g, 0.08 mmol) and sodium hydroxide (0.2 g, 5.0 
mmol). The residue was placed on a column of silica gel and eluted with CH2Cl2/EtOAc (99:1) to 
yield compound (P,S)-(+)-4e as a colourless foam (0.065 g, 89%). [α]D25 +36.8 (c 1.3, CHCl3). νmax 
(DCM)/cm-1 3372, 2928, 2858, 1618, 1584, 1492, 1111, 939, 849, 735; δH (400 MHz, CDCl3) 0.90 
(12 H, t , J 7.0 Hz), 1.19-1.38 (48 H, m), 2.10-2.29 (8 H, m), 4.28 (4 H, t, J 7.9 Hz), 4.55 (4 H, 
septet, J 6.1 Hz), 6.35 (4 H, s), 7.23 (4 H, s), 7.72 (4 H, s); δC (100 MHz, CDCl3) 14.2, 21.8, 21.9, 
22.7, 27.8, 33.4, 34.0, 37.6, 71.7, 102.5, 123.7, 125.4, 125.6, 151.7, 152.8; m/z (FAB): 937.6571 
[M+H]+; [C60H88O8+H]
+ requires 937.6557. 
 
General procedure 3 followed using 11e (0.11 g, 0.08 mmol) and sodium hydroxide (0.44 g, 11.0 
mmol). The residue was placed on a column of silica gel and eluted with CH2Cl2/EtOAc (99:1) to 





Using general procedure 3: 
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General procedure 3 followed using 10e’ (0.09 g, 0.08 mmol) and sodium hydroxide (0.2 g, 5.0 
mmol). The residue was placed on a column of silica gel and eluted with CH2Cl2/EtOAc (99:1) to 
yield compound (M,R)-(−)-4e as a colourless foam (0.06 g, 82%). [α]D25 −36.5 (c 1.2, CHCl3). νmax 
(DCM)/cm-1 3372, 2928, 2858, 1618, 1584, 1492, 1111, 939, 849, 735; δH (400 MHz, CDCl3) 0.90 
(12 H, t , J 7.0 Hz), 1.19-1.38 (48 H, m), 2.10-2.29 (8 H, m), 4.28 (4 H, t, J 7.9 Hz), 4.55 (4 H, 
septet, J 6.1 Hz), 6.35 (4 H, s), 7.23 (4 H, s), 7.72 (4 H, s); δC (100 MHz, CDCl3) 14.2, 21.8, 21.9, 
22.7, 27.8, 33.4, 34.0, 37.6, 71.7, 102.5, 123.7, 125.4, 125.6, 151.7, 152.8; m/z (FAB): 936.6474 
(M+); [C60H88O8]
+ requires 936.6474. 
 
General procedure 3 followed using 11e’ (0.175 g, 0.13 mmol) and sodium hydroxide (0.90 g, 
22.5 mmol). The residue was placed on a column of silica gel and eluted with CH2Cl2/EtOAc (99:1) 





Using general procedure 3: 
General procedure 3 followed using 11f (0.10 g, 0.07 mmol) and sodium hydroxide (0.44 g, 11.0 
mmol). The residue was placed on a column of silica gel and eluted with CH2Cl2 to yield compound 
(P,S)-(+)-4f as a colourless foam (0.051 g, 72%). [α]D25 +12.0 (c 1.0, CHCl3). νmax (DCM)/cm-1 
3370, 2927, 2857, 1619, 1585, 1493, 1166, 973; δH (400 MHz, CDCl3) 0.90 (12 H, t, J 7.0 Hz), 
1.20-1.37 (24 H, m), 1.60-1.75 (8 H, m), 1.83-1.97 (24 H, m), 2.03 (4 H, m), 2.13 (4 H, m), 4.24 (4 
H, t, J 7.8 Hz), 4.78 (4 H, m), 6.36 (4 H, s), 7.23 (4 H, s), 7.62 (4 H, s); δC (100 MHz, CDCl3); 
14.2, 22.7, 23.7, 24.0, 27.7, 31.9, 32.4, 32.9, 33.2, 34.0, 81.1, 102.5, 123.6, 125.1, 125.3, 152.0, 
152.7; m/z (FAB): 1041.7179 [M+H]+; [C68H96O8+H]
+ requires 1041.7183. 
 
General procedure 3 followed using 10f (0.10 g, 0.08 mmol) and sodium hydroxide (0.22 g, 5.5 
mmol). The residue was placed on a column of silica gel and eluted with CH2Cl2 to yield compound 






Using general procedure 3: 
General procedure 3 followed using 11f’ (0.11 g, 0.07 mmol) and sodium hydroxide (0.44 g, 11.0 
mmol). The residue was placed on a column of silica gel and eluted with CH2Cl2 to yield compound 
(M,R)-(−)-4f as a colourless foam (0.06 g, 76%). [α]D25 −12.3 (c 1.1, CHCl3). νmax (DCM)/cm-1 
3370, 2927, 2857, 1619, 1585, 1493, 1166, 973; δH (400 MHz, CDCl3) 0.90 (12 H, t, J 7.0 Hz), 
1.20-1.37 (24 H, m), 1.60-1.75 (8 H, m), 1.83-1.97 (24 H, m), 2.03 (4 H, m), 2.13 (4 H, m), 4.24 (4 
H, t, J 7.8 Hz), 4.78 (4 H, m), 6.36 (4 H, s), 7.23 (4 H, s), 7.62 (4 H, s); δC (100 MHz, CDCl3); 
14.2, 22.7, 23.7, 24.0, 27.7, 31.9, 32.4, 32.9, 33.2, 34.0, 81.1, 102.5, 123.6, 125.1, 125.3, 152.0, 
152.7; m/z (FAB): 1041.7176 [M+H]+; [C68H96O8+H]
+ requires 1041.7183. 
 
Using general procedure 3: 
General procedure 3 followed using 10f’ (0.11 g, 0.09 mmol) and sodium hydroxide (0.22 g, 5.5 
mmol). The residue was placed on a column of silica gel and eluted with CH2Cl2 to yield compound 





Using general procedure 3: 
General procedure 3 followed using 13a (0.24 g, 0.15 mmol) and sodium hydroxide (2.0 g, 50.0 
mmol). The residue was placed on a column of silica gel and eluted with Petroleum Ether/EtOAc 
(8:2) to yield compound (P,S)-(+)-7 as a colourless foam (0.09 g, 80%). [α]D25 +65.3 (c 1.1, 
CHCl3). νmax (DCM)/cm-1 3397, 2952, 2866, 1618, 1588, 1496, 1089, 908; δH (400 MHz, CDCl3) 
0.94 (12 H, d, J 6.8 Hz), 0.94 (12 H, d, J 6.8 Hz), 1.44 (4 H, septet, J 6.8 Hz), 2.07 (8 H, t, J 7.2 
Hz), 3.83 (12 H, s), 4.41 (4 H, t, J 7.8 Hz), 6.35 (4 H, s), 7.21 (4 H, s), 7.54 (4 H, s); δC (100 MHz, 





Using general procedure 3: 
General procedure 3 followed using 13a’ (0.2 g, 0.12 mmol) with sodium hydroxide (2.0 g, 50.0 
mmol). The residue was placed on a column of silica gel and eluted with Petroleum Ether/EtOAc 
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(8:2) to yield (M,R)-(−)-7 as a colourless foam (0.07 g, 74%). [α]D25 −65.5 (c 1.0, CHCl3). νmax 
(DCM)/cm-1 3397, 2952, 2866, 1618, 1588, 1496, 1089, 908; δH (400 MHz, CDCl3) 0.94 (12 H, d, 
J 6.8 Hz), 0.94 (12 H, d, J 6.8 Hz), 1.44 (4 H, septet, J 6.8 Hz), 2.07 (8 H, t, J 7.2 Hz), 3.83 (12 H, 
s), 4.41 (4 H, t, J 7.8 Hz), 6.35 (4 H, s), 7.21 (4 H, s), 7.54 (4 H, s); δC (100 MHz, CDCl3) 22.7, 
22.8, 26.0, 30.6, 42.9, 55.9, 100.0, 124.0, 124.5, 124.6, 152.9, 153.6. 
 
Using general procedure 3: 
General procedure 3 followed using 13b (0.22 g, 0.14 mmol) with sodium hydroxide (2.0 g, 50.0 
mmol). The residue was placed on a column of silica gel and eluted with Petroleum Ether/EtOAc 
(8:2) to yield (M,R)-(−)-7 as a colourless foam (0.08 g, 78%). [α]D25 −65.6 (c 6.2, CHCl3). νmax 
(DCM)/cm-1 3397, 2952, 2866, 1618, 1588, 1496, 1089, 908; δH (400 MHz, CDCl3) 0.94 (12 H, d, 
J 6.8 Hz), 0.94 (12 H, d, J 6.8 Hz), 1.44 (4 H, septet, J 6.8 Hz), 2.07 (8 H, t, J 7.2 Hz), 3.83 (12 H, 
s), 4.41 (4 H, t, J 7.8 Hz), 6.35 (4 H, s), 7.21 (4 H, s), 7.54 (4 H, s); δC (100 MHz, CDCl3) 22.7, 
22.8, 26.0, 30.6, 42.9, 55.9, 100.0, 124.0, 124.5, 124.6, 152.9, 153.6. 
 
Tetrabenzoxazine (P,R,S)-5: 6b 
 
Tetracyclopentyloxyresorcinarene (M,R)-(−)-4f (0.04 g, 0.04 mmol) was dissolved in dry toluene (5 
mL) in a 25 mL oven dried round-bottomed flask under nitrogen. N,N-bis(methoxymethyl)-(R)-(+)-
N--methylbenzylamine (0.08 g, 0.38 mmol) in toluene (1 mL) was added in one portion and the 
reaction mixture heated under reflux for 5 days. After this time, the reaction was allowed to cool to 
room temperature and the solvent removed under reduced pressure. The residue was placed on a 
column of silica gel and eluted with Petroleum Ether/EtOAc (85:15) to yield tetrabenzoxazine 
(P,R,S)-5 as a colourless foam (0.036 g, 58%). [α]D25 +129.8 (c 1.6, CHCl3). νmax (DCM)/cm-1 
2953, 2867, 1583, 1464, 1321, 1228, 1170, 1117, 939; δH (400 MHz, 50 °C, CDCl3) 0.87 (12 H, t, 
J 5.8 Hz), 1.12-1.33 (40 H, m), 1.39 (12 H, d, J 6.0 Hz), 1.44-1.59 (16 H, m), 1.62-1.81 (4 H, m), 
1.93-2.08 (4 H, m), 3.84 (4 H, q, J 6.5 Hz), 3.87 and 4.18 (8 H, AB, J 17.0 Hz), 4.29 (4 H, m), 
4.44 (4 H, t, J 7.2 Hz), 4.66 (8 H, m), 6.87 (4 H, m), 7.19-7.36 (20 H, m); δC (100 MHz, CDCl3) 
14.2, 21.5, 22.7, 23.6, 23.7, 28.1, 32.1, 32.6, 32.8, 36.1, 36.7, 45.4, 57.1, 79.6, 84.5, 112.5, 125.4, 
125.5, 127.2, 127.5, 128.4, 144.3, 150.0, 152.4; m/z LRMS (ESI): 1623 [M+H]+; 
[C108H140O8N4+H]
+ requires 1623 (the isotopic distribution of the observed data matched the 





Tetraisopropyloxyresorcinarene (P,S)-(+)-4e (0.06 g, 0.06 mmol) was dissolved in dry toluene (5 
mL) in a 25 mL oven-dried round-bottomed flask under nitrogen. N,N-bis(methoxymethyl)-(R)-(+)-
N--methylbenzylamine (0.13 g, 0.64 mmol) in toluene (1 mL) was added in one portion and the 
reaction mixture was heated under reflux for 5 days under nitrogen. After this time, the reaction was 
allowed to cool to room temperature and the solvent was removed under reduced pressure. The 
residue was placed on a column of silica gel and eluted with Petroleum Ether/EtOAc (8:2) to yield 
tetrabenzoxazine (M,R,R)-6 as a yellow foam (0.097 g, 53%). [α]D25 −9.1 (c 1.5, CHCl3). νmax 
(DCM)/cm-1 2968, 2926, 2857, 1461, 1110, 942, 700; δH (400 MHz, 50 °C, CDCl3) 0.82-0.94 (24 
H, m), 1.03 (12 H, d, J 5.2 Hz), 1.18-1.32 (24 H, m), 1.41 (12 H, d, J 6.4 Hz), 1.67-1.76 (4 H, m), 
1.92-2.04 (4 H, m), 3.72-3.92 (12 H, m), 4.10 (4 H, m), 4.34 (4 H, t, J 7.2 Hz), 4.52 and 4.93 (8 H, 
AB, J 10.0 Hz), 6.86 (4 H, s), 7.18-7.34 (20 H, m); δC (100 MHz, CDCl3) 14.2, 21.2, 22.3, 22.5, 
22.7, 27.9, 32.0, 36.3, 36.5, 46.7, 57.8, 74.0, 78.8, 113.3, 125.7, 127.0, 127.4, 128.3, 144.5, 150.1, 
152.0; m/z (FAB): 1518.0123 [M+H]+; [C100H132O8N4+H]
+ requires 1518.0144. 
 
Tetrabenzoxazine (M,S,R)-14: 6b 
 
Tetramethoxyresorcinarene (P,S)-(+)-4b (0.17 g, 0.21 mmol) was dissolved in dry toluene (5 mL) in 
a 25 mL oven dried round-bottomed flask under nitrogen. N,N-bis(methoxymethyl)-(S)-(–)-N--
methylbenzylamine (0.258 g, 1.24 mmol) in toluene (1 mL) was added in one portion and the 
reaction mixture heated under reflux for 4 days. After this time, the reaction was allowed to cool to 
room temperature and the solvent removed under reduced pressure. The residue was placed on a 
column of silica gel and eluted with Petroleum Ether/EtOAc (8:2) to yield tetrabenzoxazine (M,S,R)-
14 as a colourless foam (0.133 g, 46%). [α]D25 −131.2 (c 1.1, CHCl3). δH (400 MHz, CDCl3) 0.87 
(12 H, t, J 6.4 Hz), 1.32-1.38 (24 H, m), 1.37 (12 H, d, J 6.4 Hz), 1.78-1.91 (8 H, m), 3.26 (12 H, 
s), 3.68 (4 H, q, J 6.4Hz), 3.77 and 4.14 (8 H, AB, J 16.8 Hz), 4.35 (4 H, t, J 7.4 Hz), 4.51 and 
4.56 (8 H, AB, J 10.0 Hz), 6.66 (4 H, s), 7.15-7.10 (20 H, s); δC (100 MHz, CDCl3) 14.2, 21.2, 
22.7, 27.9, 32.3, 35.4, 35.8, 44.7, 57.3, 60.0, 79.5, 112.2, 124.5, 127.3, 127.5, 127.8, 128.4, 128.8, 
144.1, 150.1, 153.6. 
 
Tetrabenzoxazine (M,S,R)-15a: 6b 
 
 46 
Tetramethoxyresorcinarene (P,S)-(+)-7 (0.10 g, 0.16 mmol) was suspended in N,N-
bis(methoxymethyl)-(S)-(–)-N--methylbenzylamine (0.33 g, 1.56 mmol) in a CEM microwave 
tube. The suspension was heated under microwave irradiation at 140 ºC for 2 x 10 min (without 
cooling). The orange oil obtained was placed on a column of silica gel and eluted with light 
petroleum/ethyl acetate (6:4) to yield tetrabenzoxazine (M,S,R)-15a as a colourless foam (0.15 g, 
71%). [α]D25 –124.7 (c 1.0, CHCl3); νmax (CHCl3) /cm–1 2951, 2864, 2359, 1589, 1469, 1365, 1235, 
1095, 942, 753; δH (400 MHz, CDCl3) 0.94 (12 H, d, J 10.0 Hz), 0.96 (12 H, d, J 10.0 Hz), 1.39 
(12 H, d, J 6.5 Hz), 1.52-1.61 (4 H, m), 1.65-1.72 (4 H, m), 1.76-1.83 (4 H, m), 3.26 (12 H, s), 
3.80 (4 H, q, J 6.5 Hz), 3.86 (4 H, d, J 17.0 Hz), 4.17 (4 H, d, J 16.9 Hz), 4.55-4.62 (12 H, m), 
6.70 (4 H, s), 7.17-7.35 (20 H, m); δC (100 MHz, CDCl3) 21.3, 22.8, 22.9, 25.9, 33.1, 44.6, 44.9, 
57.2, 60.1, 79.6, 112.3, 124.7, 127.3, 127.6, 128.4, 128.7, 144.0, 150.0, 153.6; m/z (FAB) 
1348.8189; C88H108O8N4 (M
+) requires 1348.8167. 
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Figure 1. Representation of Resorcin[4]arenes, including Axial Stereochemistry 
 
Scheme 1. Formation of Racemic Tetraalkoxyresorcinarenes 
 
Figure 2. Absolute Configurations of Chiral Non-racemic Tetrabenzoxazines and a Racemic 
Resorcinarene 
 
Scheme 2. The Formation of Tetracamphorsulfonates from Racemic Resorcinarenes 
 
Scheme 3. The Formation of Tri- and Tetracamphorsulfonates from the Racemic Resorcinarene 4b 
 
Figure 3. X-ray Structure of the Tetracamphorsulfonate (M,S,R)-8a; the hydrogen atoms are 
omitted for clarity. 
 
Figure 4. X-ray Structure of the Tetracamphorsulfonate (M,S,R)-8b; the hydrogen atoms are 
omitted for clarity. 
 
Scheme 4. The Formation of Monocamphorsulfonates from the Racemic Resorcinarene 4e 
 
Scheme 5. The Formation of Dicamphorsulfonates from the Racemic Resorcinarenes 4e and 4f 
 
Scheme 6. The Formation of Mono- and Dicamphorsulfonates from the Anions Of the Racemic 
Resorcinarene 4b 
 
Scheme 7. The Formation of Tetracamphorsulfonates from a Tetra-anion 
 
Scheme 8. The Formation of Tetra(methoxymethyl)ethers from Tetra-anions 
 
Scheme 9. The Formation of Dicamphorsulfonates from Tetra-anions 
 




Scheme 11. The Formation of Tetracamphorsulfonates from the Racemic Resorcinarene 7 Using 
(R)-(–)-10-Camphorsulfonyl chloride 
 
Figure 5. X-ray Structure of the Tetracamphorsulfonate (M,S,R)-13a; the hydrogen atoms are 
omitted for clarity. 
 
Figure 6. X-ray Structure of the Tetracamphorsulfonate (P,R,S)-13b; the hydrogen atoms are 
omitted for clarity. 
 
Figure 7. The 1H NMR spectrum of Tetracamphorsulfonate (M,S,R)-8b 
 
Figure 8. The 1H NMR spectrum of Tetracamphorsulfonate (P,S,S)-8b’ 
 
Scheme 12. Hydrolyses of the First Eluting Tetracamphorsulfonates Derived from (S)-(+)-10-
Camphorsulfonyl chloride 
 
Scheme 13. Hydrolyses of the First Eluting Dicamphorsulfonates Derived from (S)-(+)-10-
Camphorsulfonyl chloride 
 
Scheme 14. Hydrolysis of the First Eluting Tetracamphorsulfonate Derived from (R)-(–)-10-
Camphorsulfonyl chloride 
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Scheme 1.  Formation of Racemic Tetraalkoxyresorcinarenes
4a, R1 = n-C3H7, R
2 = Me
4b, R1 =  n-C5H11,R
2 = Me
4c, R1 = n-C7H15, R
2 = Me
4d, R1 =  n-C11H23, R
2 = Me
4e, R1 = n-C5H11, R
2 = i-Pr
4f,  R1 = n-C5H11, R
2 = cyclopentyl
Racemic
3a, R2 = Me
3b, R2 = i-Pr



































































Figure 2. Absolute Configurations of Chiral Non-racemic Tetrabenzoxazines and a Racemic 
Resorcinarene 
 
R ac emi c
4a, R1 =  n-C3H 7
4b, R1 =  n-C5H 11
4c, R1 =  n-C7H 15
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8b, R 1 = n-C5H 11
8c, R 1 = n-C7H 15
8d, R 1 = n-C11H 23
8a', R 1 =  n-C 3H7
8b' , R1 =  n-C 5H11
8c ', R1 =  n-C 7H15
8d' , R1 =  n-C 11H23
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Figure 3. X-ray Structure of the Tetracamphorsulfonate (M,S,R)-8a; the hydrogen atoms are 
omitted for clarity. 
 
Figure 4. X-ray Structure of the Tetracamphorsulfonate (M,S,R)-8b; the hydrogen atoms are 
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Scheme 8. The Formation of Tetra(methoxymethyl)ethers from Tetra-anions
(i) n-BuLi (4.2 equiv.),
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Sc he me 10 . The F orma tion of  Te tra camphorsulfona tes f rom the  Ra cemic  Resorc ina rene 7
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    THF, 0 C
(i i)
(i ii ) then  to RT
     12  h
(8  equ iv.)




























Sc he m e 11. T he  Format ion of Te tr ac a mphorsul fona te s from the  Ra c emic  Re sorcina rene  7












(i ) n -BuLi (8  equiv .), 
    THF, 0  C
(i i)
(i ii ) then to RT
     12 h
(8 equiv.)









Figure 5. X-ray Structure of the Tetracamphorsulfonate (M,S,R)-13a; the hydrogen atoms are 
omitted for clarity. 
 
 
Figure 6. X-ray Structure of the Tetracamphorsulfonate (P,R,S)-13b; the hydrogen atoms are 





Figure 7. The 1H NMR spectrum of Tetracamphorsulfonate (M,S,R)-8b 
 
 














8a,   R1 = n-C3H7
8b,   R1 = n-C5H11
8c,   R1 = n-C7H15
8d,   R1 = n-C11H23
13a, R1 = 2-methylpropyl
Scheme 12. Hydrolyses of the First Eluting Tetracamphorsulfonates Derived from











(P,S)-(+)-4a, R1 = n-C3H7
(P,S)-(+)-4b, R1 = n-C5H11
(P,S)-(+)-4c, R1 = n-C7H15
(P,S)-(+)-4d, R1 = n-C11H23
(P,S)-(+)-7, R1 = 2-methylpropyl
NaOH, EtOH/H2O













11e, R1 = n-C5H11, R
2 = i-Pr




Scheme 13. Hydrolyses of the First Eluting Dicamphorsulfonates Derived from












    reflux, 36 h
(P,S)-(+)-4e, R1 = n-C5H11, R
2 = i-Pr


















13b,  R1 = 2-methylpropyl
P
O
Scheme 14. Hydrolysis of the First Eluting Tetracamphorsulfonate Derived from
                    (R)-(Š)-10-Camphorsulfonyl chloride
NaOH, EtOH/H2O






































































(M ,S,R )-15a (P ,S,S) -15b
mµ
+
S ch em e 15 The  Synthe sis of  Te tra be nzoxa zi nes from Ra ce mic  























(M ,S,R )-14, R =  n-C 5H1 1
M






















(M ,S,R )-6, R  = n-C5H 11
M
O O
O
O
R R
R R
O
O
O
N
N
N
N
O
P h
Ph
P h
Ph
Me
M e
M e
Me P
M P
  
 
 
